10-Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________________
FORM 10-Q
|
| | | |
| þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2016
OR
|
| | | |
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from _________ to ___________
Commission file number 1-32532
ASHLAND INC.
(a Kentucky corporation)
I.R.S. No. 20-0865835
50 E. RiverCenter Boulevard
P.O. Box 391
Covington, Kentucky 41012-0391
Telephone Number (859) 815-3333
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). Yes þ No o
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check One):
|
| | | |
| Large Accelerated Filer þ | | Accelerated Filer o |
| Non-Accelerated Filer o | | Smaller Reporting Company o |
| (Do not check if a smaller reporting company.) |
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ
At March 31, 2016, there were 62,060,722 shares of Registrant’s Common Stock outstanding.
PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
STATEMENTS OF CONSOLIDATED COMPREHENSIVE INCOME
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31 | | March 31 |
(In millions except per share data - unaudited) | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
Sales | $ | 1,247 |
| | $ | 1,350 |
| | $ | 2,410 |
| | $ | 2,741 |
|
Cost of sales | 823 |
| | 925 |
| | 1,595 |
| | 1,906 |
|
Gross profit | 424 |
| | 425 |
| | 815 |
| | 835 |
|
| | | | | | | |
Selling, general and administrative expense | 258 |
| | 203 |
| | 483 |
| | 429 |
|
Research and development expense | 25 |
| | 25 |
| | 49 |
| | 50 |
|
Equity and other income (loss) | 6 |
| | (4 | ) | | 15 |
| | 6 |
|
Operating income | 147 |
| | 193 |
| | 298 |
| | 362 |
|
| | | | | | | |
Net interest and other financing expense | 43 |
| | 40 |
| | 85 |
| | 81 |
|
Net loss on divestitures | (2 | ) | | (33 | ) | | — |
| | (118 | ) |
Income from continuing operations before income taxes | 102 |
| | 120 |
| | 213 |
| | 163 |
|
Income tax expense - Note J | 15 |
| | 25 |
| | 35 |
| | 27 |
|
Income from continuing operations | 87 |
| | 95 |
| | 178 |
| | 136 |
|
Income (loss) from discontinued operations | | | | | | | |
(net of tax) - Note D | — |
| | 129 |
| | (2 | ) | | 121 |
|
Net income | $ | 87 |
| | $ | 224 |
| | $ | 176 |
| | $ | 257 |
|
| | | | | | | |
PER SHARE DATA | | | | | | | |
Basic earnings per share - Note M | |
| | |
| | |
| | |
|
Income from continuing operations | $ | 1.39 |
| | $ | 1.40 |
| | $ | 2.79 |
| | $ | 1.97 |
|
Income (loss) from discontinued operations | — |
| | 1.90 |
| | (0.03 | ) | | 1.76 |
|
Net income | $ | 1.39 |
| | $ | 3.30 |
| | $ | 2.76 |
| | $ | 3.73 |
|
| | | | | | | |
Diluted earnings per share - Note M | |
| | |
| | |
| | |
|
Income from continuing operations | $ | 1.38 |
| | $ | 1.39 |
| | $ | 2.76 |
| | $ | 1.95 |
|
Income (loss) from discontinued operations | — |
| | 1.87 |
| | (0.03 | ) | | 1.73 |
|
Net income | $ | 1.38 |
| | $ | 3.26 |
| | $ | 2.73 |
| | $ | 3.68 |
|
| | | | | | | |
DIVIDENDS PAID PER COMMON SHARE | $ | 0.39 |
| | $ | 0.34 |
| | $ | 0.78 |
| | $ | 0.68 |
|
| | | | | | | |
COMPREHENSIVE INCOME (LOSS) | | | | | | | |
Net income | $ | 87 |
| | $ | 224 |
| | $ | 176 |
| | $ | 257 |
|
Other comprehensive income (loss), net of tax - Note N | | | | | | | |
Unrealized translation gain (loss) | 80 |
| | (255 | ) | | 19 |
| | (382 | ) |
Pension and postretirement obligation adjustment | 24 |
| | (6 | ) | | 21 |
| | (11 | ) |
Unrealized gain on available-for-sale securities | 3 |
| | — |
| | 9 |
| | — |
|
Other comprehensive income (loss) | 107 |
| | (261 | ) | | 49 |
| | (393 | ) |
Comprehensive income (loss) | $ | 194 |
| | $ | (37 | ) | | $ | 225 |
| | $ | (136 | ) |
SEE NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
|
| | | | | | | |
| March 31 |
| | September 30 |
|
(In millions - unaudited) | 2016 |
| | 2015 |
|
| | | |
ASSETS | | | |
Current assets | | | |
Cash and cash equivalents | $ | 1,136 |
| | $ | 1,257 |
|
Accounts receivable (a) | 935 |
| | 961 |
|
Inventories - Note G | 726 |
| | 706 |
|
Other assets | 115 |
| | 169 |
|
Total current assets | 2,912 |
| | 3,093 |
|
Noncurrent assets | |
| | |
|
Property, plant and equipment | | | |
Cost | 4,252 |
| | 4,144 |
|
Accumulated depreciation | 2,086 |
| | 1,962 |
|
Net property, plant and equipment | 2,166 |
| | 2,182 |
|
Goodwill - Note H | 2,578 |
| | 2,486 |
|
Intangibles - Note H | 1,110 |
| | 1,142 |
|
Restricted investments - Note F | 280 |
| | 285 |
|
Asbestos insurance receivable - Note L | 171 |
| | 180 |
|
Equity and other unconsolidated investments | 64 |
| | 65 |
|
Deferred income taxes | 213 |
| | 212 |
|
Other assets | 407 |
| | 409 |
|
Total noncurrent assets | 6,989 |
| | 6,961 |
|
Total assets | $ | 9,901 |
| | $ | 10,054 |
|
| | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | |
| | |
|
Current liabilities | |
| | |
|
Short-term debt - Note I | $ | 694 |
| | $ | 326 |
|
Current portion of long-term debt - Note I | 55 |
| | 55 |
|
Trade and other payables | 519 |
| | 573 |
|
Accrued expenses and other liabilities | 434 |
| | 488 |
|
Total current liabilities | 1,702 |
| | 1,442 |
|
Noncurrent liabilities | |
| | |
|
Long-term debt - Note I | 3,328 |
| | 3,348 |
|
Employee benefit obligations - Note K | 1,013 |
| | 1,076 |
|
Asbestos litigation reserve - Note L | 636 |
| | 661 |
|
Deferred income taxes | 85 |
| | 85 |
|
Other liabilities | 414 |
| | 405 |
|
Total noncurrent liabilities | 5,476 |
| | 5,575 |
|
Commitments and contingencies - Note L |
|
| |
|
|
Stockholders’ equity | 2,723 |
| | 3,037 |
|
| | | |
Total liabilities and stockholders’ equity | $ | 9,901 |
| | $ | 10,054 |
|
| | | |
| |
(a) | Accounts receivable includes an allowance for doubtful accounts of $11 million at March 31, 2016 and September 30, 2015. |
SEE NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
STATEMENT OF CONSOLIDATED STOCKHOLDERS’ EQUITY
|
| | | | | | | | | | | | | | | | | | | |
(In millions - unaudited) | Common stock |
| | Paid-in capital |
| | Retained earnings |
| | Accumulated other comprehensive income (loss) |
| (a) | Total |
|
BALANCE AT SEPTEMBER 30, 2015 | $ | 1 |
| | $ | 46 |
| | $ | 3,281 |
| | $ | (291 | ) |
| $ | 3,037 |
|
Total comprehensive income | |
| | | | 176 |
| | 49 |
|
| 225 |
|
Regular dividends, $.78 per common share | |
| | |
| | (48 | ) | | |
| | (48 | ) |
Common shares issued under stock | |
| | |
| | |
| | |
| | |
|
incentive and other plans (b) | |
| | 9 |
| | | | |
| | 9 |
|
Repurchase of common shares (c) | | | (49 | ) | | (451 | ) | | | | (500 | ) |
BALANCE AT MARCH 31, 2016 | $ | 1 |
| | $ | 6 |
| | $ | 2,958 |
| | $ | (242 | ) |
| $ | 2,723 |
|
| | | | | | | | | |
| |
(a) | At March 31, 2016 and September 30, 2015, the after-tax accumulated other comprehensive loss of $242 million and $291 million, respectively, was comprised of unrecognized prior service credits as a result of certain employee benefit plan amendments of $62 million and $41 million, respectively, net unrealized translation loss of $302 million and $321 million, respectively, and net unrealized loss on available-for-sale securities of $2 million and $11 million, respectively. |
| |
(b) | Common shares issued were 318,033 for the six months ended March 31, 2016. |
| |
(c) | Common shares repurchased were 5,049,911 for the six months ended March 31, 2016. See Note N of the Notes to Condensed Consolidated Financial Statements. |
SEE NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
STATEMENTS OF CONDENSED CONSOLIDATED CASH FLOWS
|
| | | | | | | |
| Six months ended |
| March 31 |
(In millions - unaudited) | 2016 |
| | 2015 |
|
CASH FLOWS PROVIDED (USED) BY OPERATING ACTIVITIES FROM | | | |
CONTINUING OPERATIONS | | | |
Net income | $ | 176 |
| | $ | 257 |
|
Loss (income) from discontinued operations (net of tax) | 2 |
| | (121 | ) |
Adjustments to reconcile income from continuing operations to | |
| | |
|
cash flows from operating activities | |
| | |
|
Depreciation and amortization | 168 |
| | 170 |
|
Debt issuance cost amortization | 6 |
| | 7 |
|
Deferred income taxes | 1 |
| | (13 | ) |
Equity income from affiliates | (8 | ) | | (7 | ) |
Distributions from equity affiliates | 9 |
| | 10 |
|
Stock based compensation expense | 17 |
| | 15 |
|
Gain on available-for-sale securities | (4 | ) | | — |
|
Net loss on divestitures | — |
| | 118 |
|
Impairment of equity investment | — |
| | 14 |
|
Pension contributions | (15 | ) | | (29 | ) |
Losses on pension and other postretirement plan remeasurements | 23 |
| | 9 |
|
Change in operating assets and liabilities (a) | (125 | ) | | (334 | ) |
Total cash flows provided by operating activities from continuing operations | 250 |
| | 96 |
|
CASH FLOWS PROVIDED (USED) BY INVESTING ACTIVITIES FROM | |
| | |
|
CONTINUING OPERATIONS | |
| | |
|
Additions to property, plant and equipment | (103 | ) | | (86 | ) |
Proceeds from disposal of property, plant and equipment | 3 |
| | 1 |
|
Purchase of operations - net of cash acquired | (66 | ) | | — |
|
Proceeds from sale of operations or equity investments | 12 |
| | 106 |
|
Funds restricted for specific transactions | — |
| | (320 | ) |
Reimbursements from restricted investments | 23 |
| | — |
|
Proceeds from the settlement of derivative instruments | 7 |
| | — |
|
Purchase of available-for-sale securities | (4 | ) | | — |
|
Proceeds from sales of available-for-sale securities | 4 |
| | — |
|
Total cash flows used by investing activities from continuing operations | (124 | ) | | (299 | ) |
CASH FLOWS PROVIDED (USED) BY FINANCING ACTIVITIES FROM | |
| | |
|
CONTINUING OPERATIONS | |
| | |
|
Repayment of long-term debt | (36 | ) | | — |
|
Proceeds (repayment) from short-term debt | 368 |
| | (96 | ) |
Repurchase of common stock | (500 | ) | | (397 | ) |
Cash dividends paid | (48 | ) | | (46 | ) |
Excess tax benefits related to share-based payments | (1 | ) | | 7 |
|
Total cash flows used by financing activities from continuing operations | (217 | ) | | (532 | ) |
CASH USED BY CONTINUING OPERATIONS | (91 | ) | | (735 | ) |
Cash provided (used) by discontinued operations | |
| | |
|
Operating cash flows | (19 | ) | | 277 |
|
Investing cash flows | — |
| | 10 |
|
Total cash provided (used) by discontinued operations | (19 | ) | | 287 |
|
Effect of currency exchange rate changes on cash and cash equivalents | (11 | ) | | (34 | ) |
DECREASE IN CASH AND CASH EQUIVALENTS | (121 | ) | | (482 | ) |
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD | 1,257 |
| | 1,393 |
|
CASH AND CASH EQUIVALENTS - END OF PERIOD | $ | 1,136 |
| | $ | 911 |
|
| | | |
| |
(a) | Excludes changes resulting from operations acquired or sold. |
SEE NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE A – SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation
The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial reporting and Securities and Exchange Commission regulations. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. These statements omit certain information and footnote disclosures required for complete annual financial statements and, therefore, should be read in conjunction with Ashland’s Annual Report on Form 10-K for the fiscal year ended September 30, 2015. Results of operations for the period ended March 31, 2016 are not necessarily indicative of the expected results for the remaining quarters in the fiscal year. Additionally, certain prior period data has been reclassified in the Condensed Consolidated Financial Statements to conform to the current period presentation, including the adoption of new accounting guidance during the current quarter related to the classification as noncurrent of all deferred tax assets and liabilities in the Condensed Consolidated Balance Sheet.
Ashland is composed of three reportable segments: Ashland Specialty Ingredients (Specialty Ingredients), Ashland Performance Materials (Performance Materials) and Valvoline.
Use of estimates, risks and uncertainties
The preparation of Ashland’s Condensed Consolidated Financial Statements requires management to make estimates and assumptions that affect the reported amounts of certain assets, liabilities, revenues, expenses and related disclosures of contingent assets and liabilities as well as qualifying subsequent events. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets (including goodwill and intangible assets), employee benefit obligations, income taxes and liabilities and receivables associated with asbestos litigation and environmental remediation. Although management bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, actual results could differ significantly from the estimates under different assumptions or conditions.
Ashland’s results are affected by domestic and international economic, political, legislative, regulatory and legal actions. Economic conditions, such as recessionary trends, inflation, interest and monetary exchange rates, government fiscal policies and changes in the prices of certain key raw materials, can have a significant effect on operations. While Ashland maintains reserves for anticipated liabilities and carries various levels of insurance, Ashland could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings relating to asbestos, environmental remediation or other matters.
New accounting standards
A description of new U.S. GAAP accounting standards issued and adopted during the current year is required in interim financial reporting. A detailed listing of new accounting standards relevant to Ashland is included in the Annual Report on Form 10-K for the fiscal year ended September 30, 2015. The following standards relevant to Ashland were either issued or adopted in the current period, or will become effective in a subsequent period.
In March 2016, the Financial Accounting Standards Board (FASB) issued new accounting guidance for certain aspects of share-based payments to employees. This guidance requires all excess tax benefits and tax deficiencies related to share-based payments to be recognized as income tax expense in the income statement instead of additional paid in capital, and changes the classification of excess tax benefits from a financing activity to an operating activity within the statement of cash flows. This guidance also allows entities to make an accounting policy election to either estimate the number of awards that are expected to vest or account for forfeitures when they occur. Lastly, this guidance increases the amount an employer can withhold to cover income taxes on awards and still qualify for equity classification and requires that cash paid by an employer
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE A – SIGNIFICANT ACCOUNTING POLICIES (continued)
when directly withholding shares for tax-withholding purposes be classified as a financing activity within the statement of cash flows. The guidance will become effective for Ashland on October 1, 2017. Early adoption is permitted in any interim or annual period. Ashland is currently evaluating the impact this guidance may have on Ashland's Condensed Consolidated Financial Statements.
In February 2016, the FASB issued new accounting guidance related to lease transactions. The main objective of this guidance is to increase transparency and comparability among organizations by requiring lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by leases and to disclose key information about leasing arrangements. The presentation of the statements of comprehensive income and the statements of cash flows is largely unchanged under this guidance. This guidance retains a distinction between finance leases and operating leases, and the classification criteria for distinguishing between finance leases and operating leases are substantially similar to the classification criteria for distinguishing between capital leases and operating leases in the current accounting literature. The guidance will become effective for Ashland on October 1, 2019. Ashland is currently evaluating the impact this guidance may have on Ashland's Condensed Consolidated Financial Statements.
In January 2016, the FASB issued accounting guidance related to the recognition and measurement of financial assets and financial liabilities. The main objective of this guidance is enhancing the reporting model for financial instruments to provide users of financial statements with more decision-useful information. The amendments in this guidance address certain aspects of recognition, measurement, presentation and disclosure of financial instruments. This guidance requires the following:
| |
• | equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income; |
| |
• | a qualitative assessment to identify impairment of equity investments without readily determinable fair values; |
| |
• | the use of the exit price notion when measuring the fair value of financial instruments for disclosure purposes; |
| |
• | an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments; and |
| |
• | separate presentation of financial assets and financial liabilities by measurement category and form of financial asset on the balance sheet or the accompanying notes to the financial statements. |
The guidance also eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet and clarifies that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale securities in combination with the entity's other deferred tax assets. The guidance will become effective for Ashland on October 1, 2018. Early application to financial statements of fiscal years or interim periods that have not yet been issued is permitted as of the beginning of the fiscal year of adoption. Ashland is currently evaluating the impact this guidance may have on Ashland's Condensed Consolidated Financial Statements.
In November 2015, the FASB issued accounting guidance requiring all deferred tax assets and liabilities to be classified as noncurrent on the balance sheet instead of separating deferred taxes into current and noncurrent amounts. During the current quarter, Ashland adopted this new guidance and applied it retrospectively to the September 30, 2015 Condensed Consolidated Balance Sheet. The impact of this new guidance within this statement resulted in the elimination of net current deferred taxes of $149 million with an increase to noncurrent deferred tax assets of $145 million and a decrease to noncurrent deferred tax liabilities of $4 million.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE B – ACQUISITIONS
Oil Can Henry's
On December 11, 2015, Ashland announced that it signed a definitive agreement to acquire OCH International, Inc. (Oil Can Henry's), which was the 14th largest quick-lube network in the United States, servicing approximately 1 million vehicles annually with 89 quick-lube stores, consisting of 47 company-owned stores and 42 franchise locations, in Oregon, Washington, California, Arizona, Idaho and Colorado. On February 1, 2016, Ashland completed the acquisition.
The acquisition of Oil Can Henry's was valued at $72 million, which included acquired indebtedness of $11 million and other working capital adjustments. Net of acquired indebtedness and certain purchase price adjustments, the net cash outlay was approximately $60 million during the March 2016 quarter. The preliminary purchase price allocation primarily included $82 million of goodwill.
Zeta Fraction™
In September 2015, Specialty Ingredients completed the acquisition of the patented Zeta Fraction™ technology from AkzoNobel for $8 million. The acquisition broadens Ashland’s value-added portfolio in the personal care, pharmaceutical, food and beverage, and agriculture markets. The patented Zeta Fraction™ process and technology selectively isolates efficacious components from living plants and marine sources to produce a wide range of biofunctional ingredients. The purchase price allocation primarily included intellectual property and property, plant and equipment.
NOTE C - DIVESTITURES
Ashland Separation of Valvoline
On September 22, 2015, Ashland announced that the Board of Directors approved proceeding with a plan to separate Ashland into two independent, publicly traded companies comprising of the new Ashland and Valvoline. Ashland has continued the process to separate its Valvoline business from its Specialty Ingredients and Performance Materials businesses while it finalizes the transaction structure and obtains customary regulatory and other approvals. Subject to market conditions, Ashland plans to pursue an initial public offering (IPO) of up to 20% of the common stock of Valvoline. Ashland expects to file a registration statement for the common stock of Valvoline with the Securities and Exchange Commission in mid-calendar year 2016 and complete the IPO during the fourth quarter of calendar year 2016. Ashland currently expects that it would distribute the remaining common stock of Valvoline to Ashland's shareholders upon expiration of the IPO lock-up (typically six months after completion of the IPO). Ashland intends for the separation, which is subject to final board approval prior to completion, to be tax free for Ashland shareholders. For the three and six months ended March 31, 2016, Ashland recognized separation costs of $12 million and $18 million, respectively, which are primarily related to consulting and legal fees and employee retention awards. Separation costs are recorded within the selling, general and administrative expense caption of the Statements of Consolidated Comprehensive Income.
The new Ashland will be a global leader in providing specialty chemical solutions to customers in a wide range of consumer and industrial markets. These markets are currently served by Specialty Ingredients and Performance Materials. Key markets and applications include pharmaceutical, personal care, food and beverage, architectural coatings, adhesives, automotive, construction and energy.
Valvoline will focus on building the world's leading engine and automotive maintenance business by providing hands-on expertise to customers in each of its primary market channels: Do-It-Yourself (DIY); Installers; Valvoline Instant Oil ChangeSM; and International.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE C – DIVESTITURES (continued)
Industrial Biocides
During May 2015, Ashland entered into a definitive sale agreement to sell the industrial biocides assets within Specialty Ingredients, which closed on July 1, 2015. As a result of the sale, Ashland received net cash proceeds of approximately $30 million and recognized a nominal gain before tax during the September 2015 quarter.
The sale of Specialty Ingredient's industrial biocides assets did not qualify for discontinued operations treatment since it did not represent a strategic shift that had or will have a major effect on Ashland's operations and financial results.
Valvoline Car Care Products
In April 2015, Ashland entered into a definitive sale agreement to sell Valvoline's car care product assets for $24 million, which included Car Brite™ and Eagle One™ automotive appearance products. Prior to the sale, Ashland recognized a loss of $26 million before tax to recognize the assets at fair value less cost to sell, using Level 2 nonrecurring fair value measurements. The loss was reported within the net loss on divestitures caption within the Statements of Consolidated Comprehensive Income during the March 2015 quarter. The transaction closed on June 30, 2015 and Ashland received net proceeds of $19 million after adjusting for certain customary closing costs and final working capital totals during the June 2015 quarter.
The sale of Valvoline's car care product assets did not qualify for discontinued operations treatment since it did not represent a strategic shift that had or will have a major effect on Ashland's operations and financial results.
Valvoline Joint Venture
During April 2015, Ashland sold a Valvoline joint venture equity investment in Venezuela. Prior to the sale, Ashland recognized a $14 million impairment in the March 2015 quarter, for which there was no tax effect, using Level 2 nonrecurring fair value measurements within the equity and other income (loss) caption of the Statements of Consolidated Comprehensive Income.
Ashland’s decision to sell the equity investment and the resulting charge recorded in the prior year was reflective of the continued devaluation of the Venezuelan currency (bolivar) based on changes to the Venezuelan currency exchange rate mechanisms during the prior year. In addition, the continued lack of exchangeability between the Venezuelan bolivar and U.S. dollar had restricted the joint venture’s ability to pay dividends and obligations denominated in U.S. dollars. These exchange regulations and cash flow limitations, combined with other recent Venezuelan regulations and the impact of declining oil prices on the Venezuelan economy, had significantly restricted Ashland’s ability to conduct normal business operations through the joint venture arrangement. Ashland determined this divestiture did not represent a strategic shift that had or will have a major effect on Ashland's operations and financial results, and thus it did not qualify for discontinued operations treatment.
Elastomers
On October 9, 2014, Ashland entered into a definitive agreement to sell the Elastomers division of the Performance Materials reportable segment, which operated a 250-person manufacturing facility in Port Neches, Texas, to Lion Copolymer Holdings, LLC. The Elastomers division, which primarily served the North American replacement tire market, accounted for approximately 5% of Ashland's 2014 sales of $6.1 billion and 18% of Ashland Performance Materials' $1.6 billion in sales in 2014. The sale was completed on December 1, 2014 in a transaction valued at approximately $120 million which was subject to working capital adjustments. The total post-closing adjusted cash proceeds received before taxes by Ashland during 2015 was $105 million, which included working capital adjustments and transaction costs, as defined in the definitive agreement.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE C – DIVESTITURES (continued)
Elastomers' net assets as of November 30, 2014 were $191 million which primarily included accounts receivable, inventory, property, plant and equipment, non-deductible goodwill and other intangibles and payables. Since the net proceeds received were less than book value, Ashland recorded a loss of $86 million pre-tax, using Level 2 nonrecurring fair value measurements, within the net loss on divestitures caption within the Statements of Consolidated Comprehensive Income during 2015. The related tax effect was a benefit of $28 million included in the income tax expense caption within the Statements of Consolidated Comprehensive Income.
Ashland determined that the sale of Elastomers did not represent a strategic shift that had or will have a major effect on Ashland's operations and financial results. As such, Elastomers' results were included in the Performance Materials reportable segment results of operations and financial position within the Statements of Consolidated Comprehensive Income and Condensed Consolidated Balance Sheets, respectively, until its December 1, 2014 sale.
MAP Transaction
As part of the 2005 transfer of Ashland's 38% interest in the Marathon Ashland Petroleum joint venture and two other small businesses to Marathon Oil Corporation (Marathon) (the MAP Transaction), Marathon is entitled to the tax deductions for Ashland's future payments of certain contingent liabilities, including asbestos liabilities, related to previously owned businesses of Ashland. Marathon agreed to compensate Ashland for these tax deductions and Ashland established a discounted receivable, which represented the estimated present value of probable recoveries from Marathon for the portion of their future tax deductions. During January 2015, as a result of an asbestos settlement, Ashland recorded a $7 million charge within the net loss on divestitures caption of the Statements of Consolidated Comprehensive Income. See Note L for more information related to this asbestos insurance settlement.
NOTE D – DISCONTINUED OPERATIONS
In previous periods, Ashland has divested certain businesses that have qualified as discontinued operations. The operating results from these divested businesses and subsequent adjustments related to ongoing assessments of certain retained liabilities and tax items have been recorded within the discontinued operations caption in the Statements of Consolidated Comprehensive Income for all periods presented and are discussed further within this note.
Ashland is subject to liabilities from claims alleging personal injury caused by exposure to asbestos. Such claims result primarily from indemnification obligations undertaken in 1990 in connection with the sale of Riley Stoker Corporation (Riley), a former subsidiary of Ashland, which qualified as a discontinued operation, and from the 2009 acquisition of Hercules, a wholly-owned subsidiary of Ashland. Adjustments to the recorded litigation reserves and related insurance receivables are recorded within discontinued operations. During the three and six months ended March 31, 2015, Ashland recorded an after-tax gain of $120 million within discontinued operations due to the January 2015 asbestos insurance settlement. See Note L for more information related to the adjustments on asbestos liabilities and receivables.
On July 31, 2014, Ashland completed the sale of the Ashland Water Technologies (Water Technologies) business to Clayton, Dubilier & Rice. Ashland has made certain post-closing adjustments as defined by the definitive agreement during the three and six months ended March 31, 2016 and 2015.
Components of amounts reflected in the Statements of Consolidated Comprehensive Income related to discontinued operations are presented in the following table for the three and six months ended March 31, 2016 and 2015.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE D – DISCONTINUED OPERATIONS (continued)
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31 | | March 31 |
(In millions) | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
Income (loss) from discontinued operations (net of tax) | | | | | | | |
Asbestos-related litigation | $ | — |
| | $ | 122 |
| | $ | — |
| | $ | 120 |
|
Water Technologies | (1 | ) | | — |
| | (1 | ) | | (2 | ) |
Gain (loss) on disposal of discontinued operations (net of tax) | |
| | |
| | |
| | |
|
Water Technologies | 1 |
| | 7 |
| | (1 | ) | | 3 |
|
Total income (loss) from discontinued operations (net of tax) | $ | — |
| | $ | 129 |
| | $ | (2 | ) | | $ | 121 |
|
NOTE E – RESTRUCTURING ACTIVITIES
Ashland periodically implements company-wide restructuring programs related to acquisitions, divestitures or other cost reduction programs in order to enhance profitability through streamlined operations and an improved overall cost structure for each business.
Severance costs
During 2014, Ashland announced a global restructuring program to streamline the resources used across the organization. As part of this global restructuring program, Ashland executed a voluntary severance offer (VSO) to certain U.S. employees and an involuntary program for certain employees. Substantially all payments related to the VSO and involuntary programs were paid by the end of fiscal year 2015. As of March 31, 2016 and September 30, 2015, the remaining restructuring reserve for this global restructuring program was $1 million and $7 million, respectively. Additional restructuring reserves of $1 million for other previously announced programs also remained as of March 31, 2016 and September 30, 2015.
Facility costs
In prior years, Ashland incurred lease abandonment charges related to its exit from an office facility that was obtained as part of the Hercules acquisition. The costs related to the reserve will be paid over the remaining lease term through May 2016. As of March 31, 2016 and September 30, 2015, the remaining restructuring reserve for all qualifying facility costs totaled $1 million and $3 million, respectively.
The following table summarizes the related activity in these reserves for the six months ended March 31, 2016 and 2015. The severance reserves and facility costs reserves are included in accrued expenses and other liabilities in the Condensed Consolidated Balance Sheets.
|
| | | | | | | | | | | |
| | | Facility |
| | |
(In millions) | Severance |
| | costs |
| | Total |
|
Balance as of September 30, 2015 | $ | 8 |
| | $ | 3 |
| | $ | 11 |
|
Utilization (cash paid) | (6 | ) | | (2 | ) | | (8 | ) |
Balance as of March 31, 2016 | $ | 2 |
| | $ | 1 |
| | $ | 3 |
|
| | | | | |
Balance as of September 30, 2014 | $ | 56 |
| | $ | 9 |
| | $ | 65 |
|
Reserve adjustments | (2 | ) | | — |
| | (2 | ) |
Utilization (cash paid) | (38 | ) | | (2 | ) | | (40 | ) |
Balance as of March 31, 2015 | $ | 16 |
| | $ | 7 |
| | $ | 23 |
|
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE E – RESTRUCTURING ACTIVITIES (continued)
Specialty Ingredients Restructuring
During the March 2015 quarter, Specialty Ingredients committed to a restructuring plan within an existing manufacturing facility. As a result, during the three months ended March 31, 2015, restructuring charges of $18 million were recorded within the cost of sales caption of the Statements of Consolidated Comprehensive Income. As of March 31, 2016 and September 30, 2015, the remaining restructuring reserve related to severance for the Specialty Ingredients manufacturing facility totaled $1 million and $13 million, respectively. During the six months ended March 31, 2016, as the structure of the program was finalized, the severance reserve was reduced by a $5 million reversal of the accrual as well as reclassifications of certain non-severance related costs. The restructuring plan is expected to be completed during fiscal 2016. The severance reserve is included in accrued expenses and other liabilities in the Condensed Consolidated Balance Sheets.
NOTE F – FAIR VALUE MEASUREMENTS
As required by U.S. GAAP, Ashland uses applicable guidance for defining fair value, the initial recording and periodic remeasurement of certain assets and liabilities measured at fair value and related disclosures for instruments measured at fair value. Fair value accounting guidance establishes a fair value hierarchy, which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). An instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the instrument’s fair value measurement. The three levels within the fair value hierarchy are described as follows.
Level 1 – Observable inputs such as unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
Level 3 – Unobservable inputs for the asset or liability for which there is little, if any, market activity at the measurement date. Unobservable inputs reflect Ashland’s own assumptions about what market participants would use to price the asset or liability. The inputs are developed based on the best information available in the circumstances, which might include Ashland’s own financial data such as internally developed pricing models, discounted cash flow methodologies, as well as instruments for which the fair value determination requires significant management judgment.
For assets that are measured using quoted prices in active markets (Level 1), the total fair value is the published market price per unit multiplied by the number of units held without consideration of transaction costs. Assets and liabilities that are measured using significant other observable inputs (Level 2) are primarily valued by reference to quoted prices of similar assets or liabilities in active markets, adjusted for any terms specific to that asset or liability. For all other assets and liabilities for which unobservable inputs are used (Level 3), fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models that Ashland deems reasonable.
The following table summarizes financial instruments subject to recurring fair value measurements as of March 31, 2016.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE F – FAIR VALUE MEASUREMENTS (continued)
|
| | | | | | | | | | | | | | | | | | | |
(In millions) | Carrying value |
| | Total fair value |
| | Quoted prices in active markets for identical assets Level 1 |
| | Significant other observable inputs Level 2 |
| | Significant unobservable inputs Level 3 |
|
Assets | | | | | | | | | |
Cash and cash equivalents | $ | 1,136 |
| | $ | 1,136 |
| | $ | 1,136 |
| | $ | — |
| | $ | — |
|
Restricted investments (a) | 310 |
| | 310 |
| | 310 |
| | — |
| | — |
|
Deferred compensation investments (b) | 186 |
| | 186 |
| | 40 |
| | 146 |
| | — |
|
Investments of captive insurance company (b) | 3 |
| | 3 |
| | 3 |
| | — |
| | — |
|
Foreign currency derivatives | 8 |
| | 8 |
| | — |
| | 8 |
| | — |
|
Total assets at fair value | $ | 1,643 |
| | $ | 1,643 |
| | $ | 1,489 |
| | $ | 154 |
| | $ | — |
|
| | | | | | | | | |
Liabilities | |
| | |
| | |
| | |
| | |
|
Foreign currency derivatives | $ | 8 |
| | $ | 8 |
| | $ | — |
| | $ | 8 |
| | $ | — |
|
| | | | | | | | | |
| |
(a) | Included in restricted investments and $30 million within other current assets in the Condensed Consolidated Balance Sheets. |
| |
(b) | Included in other noncurrent assets in the Condensed Consolidated Balance Sheets. |
The following table summarizes financial asset instruments subject to recurring fair value measurements as of September 30, 2015.
|
| | | | | | | | | | | | | | | | | | | |
(In millions) | Carrying value |
| | Total fair value |
| | Quoted prices in active markets for identical assets Level 1 |
| | Significant other observable inputs Level 2 |
| | Significant unobservable inputs Level 3 |
|
Assets | |
| | |
| | |
| | |
| | |
|
Cash and cash equivalents | $ | 1,257 |
| | $ | 1,257 |
| | $ | 1,257 |
| | $ | — |
| | $ | — |
|
Restricted investments (a) | 315 |
| | 315 |
| | 315 |
| | — |
| | — |
|
Deferred compensation investments (b) | 180 |
| | 180 |
| | 40 |
| | 140 |
| | — |
|
Investments of captive insurance company (b) | 4 |
| | 4 |
| | 4 |
| | — |
| | — |
|
Foreign currency derivatives | 13 |
| | 13 |
| | — |
| | 13 |
| | — |
|
Total assets at fair value | $ | 1,769 |
| | $ | 1,769 |
| | $ | 1,616 |
| | $ | 153 |
| | $ | — |
|
| | | | | | | | | |
Liabilities | |
| | |
| | |
| | |
| | |
|
Foreign currency derivatives | $ | 16 |
| | $ | 16 |
| | $ | — |
| | $ | 16 |
| | $ | — |
|
| | | | | | | | | |
| |
(a) | Included in restricted investments and $30 million within other current assets in the Condensed Consolidated Balance Sheets. |
| |
(b) | Included in other noncurrent assets in the Condensed Consolidated Balance Sheets. |
Restricted investments
On January 13, 2015, Ashland and Hercules, a wholly owned subsidiary of Ashland that was acquired in 2009, entered into a comprehensive settlement agreement related to certain insurance coverage for asbestos bodily injury claims with Underwriters at Lloyd’s, certain London Companies and Chartis (AIG) member companies, along with National Indemnity Company and Resolute Management, Inc., under which Ashland and Hercules received a total of $398 million (the January 2015 asbestos insurance settlement). During the March 2015
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE F – FAIR VALUE MEASUREMENTS (continued)
quarter, Ashland placed $335 million of the settlement funds from the January 2015 asbestos insurance settlement into a renewable annual trust restricted for the purpose of paying ongoing and future litigation defense and claim settlement costs incurred in conjunction with asbestos claims. These funds were classified primarily as noncurrent restricted investment assets, with $30 million classified within other current assets, in the Condensed Consolidated Balance Sheets as of March 31, 2016 and September 30, 2015.
During the June 2015 quarter, Ashland diversified the restricted investments received from the January 2015 asbestos insurance settlement into primarily equity and corporate bond mutual funds that are designated as available-for-sale securities, classified as Level 1 measurements within the fair value hierarchy. Available-for-sale securities are reported at fair value with unrealized gains and losses, net of related deferred income taxes, included in the stockholders' equity section of the Condensed Consolidated Balance Sheets as a component of accumulated other comprehensive income (AOCI). Investment income and realized gains and losses on the available-for-sale securities are reported in the net interest and other financing expense caption in the Statements of Consolidated Comprehensive Income. The following table provides a summary of the available-for-sale securities portfolio as of March 31, 2016 and September 30, 2015:
|
| | | | | | | | | | | | | | | |
| Demand |
| | Equity |
| | Corporate Bond |
| | |
(In millions) | Deposit |
| | Mutual Fund |
| | Mutual Fund |
| | Total |
|
As of March 31, 2016 | | | | | | | |
Original cost | $ | 20 |
| | $ | 195 |
| | $ | 120 |
| | $ | 335 |
|
Accumulated investment income | | | | | | |
|
|
and disbursements | (3 | ) | | — |
| | — |
| | (3 | ) |
Adjusted cost (a) | 17 |
| | 195 |
| | 120 |
| | 332 |
|
Investment income (b) | 4 |
| | — |
| | — |
| | 4 |
|
Unrealized loss | — |
| | (3 | ) | | — |
| | (3 | ) |
Purchases (Sales) | 4 |
| | (4 | ) | | — |
| | — |
|
Disbursements | (23 | ) | | — |
| | — |
| | (23 | ) |
Fair value | $ | 2 |
| | $ | 188 |
| | $ | 120 |
| | $ | 310 |
|
| | | | | | | |
As of September 30, 2015 | | | | | | | |
Original cost | $ | 20 |
| | $ | 195 |
| | $ | 120 |
| | $ | 335 |
|
Investment income (b) | 3 |
| | — |
| | — |
| | 3 |
|
Unrealized loss | — |
| | (14 | ) | | (3 | ) | | (17 | ) |
Disbursements | (6 | ) | | — |
| | — |
| | (6 | ) |
Fair value | $ | 17 |
| | $ | 181 |
| | $ | 117 |
| | $ | 315 |
|
| | | | | | | |
(a) The adjusted cost of the demand deposit includes accumulated investment income and disbursements recorded in previous periods.
| |
(b) | Investment income for the demand deposit includes interest income as well as dividend income transferred from the equity and corporate bond mutual funds. |
The unrealized losses as of March 31, 2016 and September 30, 2015 were recognized within AOCI. At March 31, 2016, Ashland considered the decline in market value of its restricted investment portfolio, which is less than twelve months in duration, to be temporary in nature and does not consider any of its investments other-than-temporarily impaired. Ashland invests in highly-rated mutual funds comprised principally of investment grade securities. No realized gain or loss was reclassified out of AOCI and no other-than-temporary impairment was recognized in AOCI during the three and six months ended March 31, 2016.
The following table presents the investment income and disbursements related to the demand deposit for the three and six months ended March 31, 2016.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE F – FAIR VALUE MEASUREMENTS (continued)
|
| | | | | | | | | |
| Three months ended | | | Six months ended | |
| | March 31 |
| | | March 31 |
|
(In millions) | | 2016 |
| | | 2016 |
|
Investment income | | $ | 2 |
| | | $ | 4 |
|
Disbursements | | (16 | ) | | | (23 | ) |
Deferred compensation investments
Deferred compensation investments consist of Level 1 and Level 2 measurements within the fair value hierarchy. Level 1 investments consist primarily of fixed income U.S. government bonds while Level 2 investments are comprised primarily of a guaranteed interest fund, a common stock index fund and an intermediate government bond fund. Gains and losses related to deferred compensation investments are immediately recognized within the Statements of Consolidated Comprehensive Income.
Derivative and hedging activities
Currency hedges
Ashland conducts business in a variety of foreign currencies. Accordingly, Ashland regularly uses foreign currency derivative instruments to manage exposure on certain transactions denominated in foreign currencies to curtail potential earnings volatility effects of certain assets and liabilities, including short-term inter-company loans, denominated in currencies other than Ashland’s functional currency of an entity. These derivative contracts generally require exchange of one foreign currency for another at a fixed rate at a future date and generally have maturities of less than twelve months. All contracts are marked-to-market with net changes in fair value recorded within the selling, general and administrative expense caption. The impacts of these contracts were largely offset by gains and losses resulting from the impact of changes in exchange rates on transactions denominated in non-functional currencies. The following table summarizes the gains and losses recognized during the three and six months ended March 31, 2016 and 2015 within the Statements of Consolidated Comprehensive Income.
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31 | | March 31 |
(In millions) | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
Foreign currency derivative gain (loss) | $ | 1 |
| | $ | (12 | ) | | $ | 4 |
| | $ | (16 | ) |
The following table summarizes the fair values of the outstanding foreign currency derivatives as of March 31, 2016 and September 30, 2015 included in accounts receivable and accrued expenses and other liabilities of the Condensed Consolidated Balance Sheets.
|
| | | | | | | |
| March 31 |
| | September 30 |
|
(In millions) | 2016 |
| | 2015 |
|
Foreign currency derivative assets | $ | 7 |
| | $ | 5 |
|
Notional contract values | 307 |
| | 192 |
|
| | | |
Foreign currency derivative liabilities | $ | 5 |
| | $ | 16 |
|
Notional contract values | 202 |
| | 673 |
|
Net investment hedges
Since 2014, Ashland has entered into foreign currency contracts in order to manage the foreign currency exposure of the net investment in certain foreign operations. These foreign currency contracts were primarily
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE F – FAIR VALUE MEASUREMENTS (continued)
the result of certain proceeds from the sale of Water Technologies being received in non-U.S. denominated currencies during 2014 and ongoing management of the volatility in foreign currency exchange rates. Ashland designated the foreign currency contracts as hedges of net investments in its foreign subsidiaries. As a result, Ashland records these hedges at fair value using forward rates, with the effective portion of the gain or loss reported as a component of the cumulative translation adjustment within AOCI and subsequently recognized in the Statements of Consolidated Comprehensive Income when the hedged item affects net income. During 2016, these foreign currency contracts were settled and Ashland entered into new foreign currency contracts designated as hedges of net investments in foreign subsidiaries. These settlements resulted in gains, within the cumulative translation adjustment within AOCI, of $7 million for the six months ended March 31, 2016.
As of March 31, 2016 and September 30, 2015, the total notional value of foreign currency contracts equaled $95 million and $175 million, respectively. The fair value of Ashland's net investment hedge assets and liabilities are calculated using forward rates. Accordingly, these instruments are deemed to be Level 2 measurements within the fair value hierarchy. Counterparties to these net investment hedges are highly rated financial institutions which Ashland believes carry only a nominal risk of nonperformance. The following table summarizes the fair value of the outstanding net investment hedge instruments as of March 31, 2016 and September 30, 2015.
|
| | | | | | | | |
| | March 31 |
| | September 30 |
|
(In millions) | Consolidated balance sheet caption | 2016 |
| | 2015 |
|
Net investment hedge assets | Accounts receivable | $ | 1 |
| | $ | 8 |
|
Net investment hedge liabilities (a) | Accrued expenses and other liabilities | 3 |
| | — |
|
| | | | |
| |
(a) | Fair value of $0 denotes a value less than $1 million. |
The following table summarizes the change in the unrealized gain (loss) on the net investment hedge instruments recognized within the cumulative translation adjustment within AOCI during the three and six months ended March 31, 2016 and 2015. No portion of the gain or loss was reclassified to income during the three and six months ended March 31, 2016 and 2015. There was no hedge ineffectiveness with these instruments during the three and six months ended March 31, 2016 and 2015.
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31 | | March 31 |
(In millions) | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
Change in unrealized gain (loss) in AOCI | $ | (2 | ) | | $ | 5 |
| | $ | (2 | ) | | $ | 5 |
|
Tax impact of change in unrealized (gain) loss in AOCI | 1 |
| | (3 | ) | | 1 |
| | (4 | ) |
Other financial instruments
At March 31, 2016 and September 30, 2015, Ashland’s long-term debt (including the current portion and excluding debt issuance cost discounts) had a carrying value of $3,409 million and $3,431 million, respectively, compared to a fair value of $3,533 million and $3,484 million, respectively. The fair values of long-term debt are based on quoted market prices or, if market prices are not available, the present values of the underlying cash flows discounted at Ashland’s incremental borrowing rates, which are deemed to be Level 2 measurements within the fair value hierarchy.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE G - INVENTORIES
Inventories are carried at the lower of cost or market. Inventories are primarily stated at cost using the weighted-average cost method. In addition, certain chemicals, plastics and lubricants are valued at cost using the last-in, first-out (LIFO) method.
The following table summarizes Ashland’s inventories as of the reported Condensed Consolidated Balance Sheet dates.
|
| | | | | | | |
| March 31 |
| | September 30 |
|
(In millions) | 2016 |
| | 2015 |
|
Finished products | $ | 559 |
| | $ | 542 |
|
Raw materials, supplies and work in process | 194 |
| | 198 |
|
LIFO reserve | (27 | ) | | (34 | ) |
| $ | 726 |
| | $ | 706 |
|
NOTE H - GOODWILL AND OTHER INTANGIBLES
Goodwill
Ashland reviews goodwill and indefinite-lived intangible assets for impairment annually or when events and circumstances indicate an impairment may have occurred. This annual assessment is performed as of July 1 and consists of Ashland determining each reporting unit’s current fair value compared to its current carrying value. For its July 1, 2015 assessment, Ashland determined that its reporting units for allocation of goodwill included the Specialty Ingredients and Valvoline reportable segments, and the Composites and Intermediates/Solvents reporting units within the Performance Materials reportable segment, and determined at that time that no impairment existed.
The following is a progression of goodwill by reportable segment for the six months ended March 31, 2016.
|
| | | | | | | | | | | | | | | |
| Specialty |
| | Performance |
| | | | |
|
(In millions) | Ingredients |
| | Materials |
| (a) | Valvoline |
| | Total |
|
Balance as of September 30, 2015 | $ | 2,004 |
| | $ | 313 |
| | $ | 169 |
| | $ | 2,486 |
|
Acquisitions (b) | — |
| | — |
| | 84 |
| | 84 |
|
Currency translation adjustment | 5 |
| | 3 |
| | — |
| | 8 |
|
Balance as of March 31, 2016 | $ | 2,009 |
| | $ | 316 |
| | $ | 253 |
| | $ | 2,578 |
|
| | | | | | | |
| |
(a) | As of March 31, 2016, goodwill consisted of $171 million for the Intermediates/Solvents reporting unit and $145 million for the Composites reporting unit. |
| |
(b) | Relates to $82 million for the acquisition of Oil Can Henry's and $2 million for Valvoline Instant Oil ChangeSM center acquisitions during the six months ended March 31, 2016. See Note B for more information on the acquisition of Oil Can Henry's. |
Other intangible assets
Intangible assets principally consist of trademarks and trade names, intellectual property and customer relationships. Intangible assets classified as finite are amortized on a straight-line basis over their estimated useful lives. The cost of trademarks and trade names is amortized principally over 3 to 25 years, intellectual property over 5 to 20 years, and customer relationships over 3 to 24 years.
As of September 30, 2015, in-process research and development (IPR&D) and certain intangible assets within trademarks and trade names were classified as indefinite-lived and had a balance of $311 million. During the six months ended March 31, 2016, Ashland started amortizing the remaining IPR&D assets since the technology was commercialized during this period. As a result, as of March 31, 2016, the indefinite-lived intangible assets consisted only of certain trademarks and trade names of $301 million. Ashland annually reviews indefinite-
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE H – GOODWILL AND OTHER INTANGIBLES (continued)
lived intangible assets for possible impairment or whenever events or changes in circumstances indicate that carrying amounts may not be recoverable.
Intangible assets were comprised of the following as of March 31, 2016 and September 30, 2015.
|
| | | | | | | | | | | |
| March 31, 2016 |
| Gross |
| | | | Net |
|
| carrying |
| | Accumulated |
| | carrying |
|
(In millions) | amount |
| | amortization |
| | amount |
|
Definite-lived intangible assets | | | | | |
Trademarks and trade names (a) | $ | 52 |
| | $ | (42 | ) | | $ | 10 |
|
Intellectual property | 821 |
| | (289 | ) | | 532 |
|
Customer relationships | 428 |
| | (161 | ) | | 267 |
|
Total definite-lived intangible assets | 1,301 |
| | (492 | ) | | 809 |
|
| | | | | |
Indefinite-lived intangible assets | | | | | |
Trademarks and trade names | 301 |
| | — |
| | 301 |
|
Total intangible assets | $ | 1,602 |
| | $ | (492 | ) | | $ | 1,110 |
|
| | | | | |
| |
(a) | Acquired trade names during the six months ended March 31, 2016 had gross carrying amounts of $2 million for Oil Can Henry's. See Note B for more information on the acquisition of Oil Can Henry's. |
|
| | | | | | | | | | | |
| September 30, 2015 |
| Gross |
| | | | Net |
|
| carrying |
| | Accumulated |
| | carrying |
|
(In millions) | amount |
| | amortization |
| | amount |
|
Definite-lived intangible assets | | | | | |
Trademarks and trade names | $ | 48 |
| | $ | (41 | ) | | $ | 7 |
|
Intellectual property | 813 |
| | (266 | ) | | 547 |
|
Customer relationships | 424 |
| | (147 | ) | | 277 |
|
Total definite-lived intangible assets | 1,285 |
| | (454 | ) | | 831 |
|
| | | | | |
Indefinite-lived intangible assets | | | | | |
IPR&D | 8 |
| | — |
| | 8 |
|
Trademarks and trade names | 303 |
| | — |
| | 303 |
|
Total intangible assets | $ | 1,596 |
| | $ | (454 | ) | | $ | 1,142 |
|
Amortization expense recognized on intangible assets was $19 million and $20 million for the three months ended March 31, 2016 and 2015, respectively, and $38 million and $41 million for the six months ended March 31, 2016 and 2015, respectively, and is included in the selling, general and administrative expense caption of the Statements of Consolidated Comprehensive Income. Estimated amortization expense for future periods is $76 million in 2016 (includes six months actual and six months estimated), $76 million in 2017, $76 million in 2018, $72 million in 2019 and $71 million in 2020. The amortization expense for future periods is an estimate. Actual amounts may change from such estimated amounts due to fluctuations in foreign currency exchange rates, additional intangible asset acquisitions and divestitures, potential impairment, accelerated amortization, or other events.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE I – DEBT
The following table summarizes Ashland’s current and long-term debt as of the dates reported in the Condensed Consolidated Balance Sheets.
|
| | | | | | | |
| March 31 |
| | September 30 |
|
(In millions) | 2016 |
| | 2015 |
|
4.750% notes, due 2022 | $ | 1,121 |
| | $ | 1,120 |
|
Term Loan, due 2020 | 1,059 |
| | 1,086 |
|
3.875% notes, due 2018 | 700 |
| | 700 |
|
Revolving credit facility | 550 |
| | 110 |
|
6.875% notes, due 2043 | 376 |
| | 376 |
|
6.50% junior subordinated notes, due 2029 | 138 |
| | 136 |
|
Accounts receivable securitization | 120 |
| | 190 |
|
Other international loans, interest at a weighted- | |
| | |
|
average rate of 5.4% at March 31, 2016 (4.8% to 9.4%) | 24 |
| | 25 |
|
Medium-term notes, due 2019, interest of 9.4% at March 31, 2016 | 5 |
| | 5 |
|
Other (a) | (16 | ) | | (19 | ) |
Total debt | 4,077 |
| | 3,729 |
|
Short-term debt | (694 | ) | | (326 | ) |
Current portion of long-term debt | (55 | ) | | (55 | ) |
Long-term debt (less current portion and debt issuance cost discounts) | $ | 3,328 |
| | $ | 3,348 |
|
| | | |
| |
(a) | Other includes $26 million and $28 million of debt issuance cost discounts as of March 31, 2016 and September 30, 2015, respectively. |
The scheduled aggregate maturities of long-term debt by year (including the current portion and excluding debt issuance costs) are as follows: $28 million remaining in 2016, $69 million in 2017, $810 million in 2018, $143 million in 2019 and $715 million in 2020. The borrowing capacity remaining under the $1.2 billion senior unsecured revolving credit facility (the 2015 revolving credit facility) was $575 million, due to an outstanding balance of $550 million, as well as a reduction of $75 million for letters of credit outstanding at March 31, 2016. Ashland's total borrowing capacity at March 31, 2016 was $654 million, which includes $79 million of available capacity from the accounts receivable securitization facility.
Accounts receivable securitization
During the December 2015 quarter, the Transfer and Administration Agreement was amended to extend the termination date of the accounts receivable securitization facility from December 31, 2015 to March 22, 2017. No other changes to the agreement within the current year amendments are expected to have a significant impact to Ashland's results of operations and financial position.
Covenant restrictions
Ashland's debt contains usual and customary representations, warranties and affirmative and negative covenants, including financial covenants for leverage and interest coverage ratios, limitations on liens, additional subsidiary indebtedness, restrictions on subsidiary distributions, investments, mergers, sale of assets and restricted payments and other customary limitations. As of March 31, 2016, Ashland is in compliance with all debt agreement covenant restrictions.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE I – DEBT (continued)
Financial covenants
The maximum consolidated leverage ratios permitted under Ashland's most recent credit agreement (the 2015 Senior Credit Agreement) are as follows: 3.75 from June 30, 2015 through December 31, 2016 and 3.5 from March 31, 2017 and each fiscal quarter thereafter. At March 31, 2016, Ashland’s calculation of the consolidated leverage ratio was 3.2, which is below the maximum consolidated leverage ratio of 3.75.
The minimum required consolidated interest coverage ratio under the 2015 Senior Credit Agreement during its entire duration is 3.0. At March 31, 2016, Ashland’s calculation of the interest coverage ratio was 5.8, which exceeds the minimum required consolidated ratio of 3.0.
NOTE J – INCOME TAXES
Current fiscal year
Ashland’s estimated annual effective income tax rate used to determine income tax expense in interim financial reporting for the year ending September 30, 2016 is 26%. Ashland’s effective tax rate in any interim period is subject to adjustments related to discrete items and changes within foreign effective tax rates resulting from income or loss fluctuations. The overall effective tax rate was 15% and 16% for the three and six months ended March 31, 2016, respectively. The current quarter and period tax rate was impacted by net favorable tax discrete items of $7 million and $13 million, respectively, primarily related to the law change from the reinstatement of the research and development credit, a favorable tax liquidation resolution and the reversal of unrecognized tax benefits due to lapse of the statute of limitations.
Prior fiscal year
Ashland’s annual effective income tax rate used to determine income tax expense in interim financial reporting for the year ending September 30, 2015 was 25%. The overall effective tax rate was 21% and 17% for the three and six months ended March 31, 2015, respectively. The prior year quarter and period tax rate was impacted by $4 million of discrete tax benefits primarily related to the release of a valuation reserve on certain deferred taxes.
Unrecognized tax benefits
Changes in unrecognized tax benefits are summarized as follows for the six months ended March 31, 2016.
|
| | | |
(In millions) | |
|
Balance at October 1, 2015 | $ | 144 |
|
Increases related to positions taken on items from prior years | 3 |
|
Decreases related to positions taken on items from prior years | (3 | ) |
Increases related to positions taken in the current year | 8 |
|
Lapse of the statute of limitations | (3 | ) |
Settlement of uncertain tax positions with tax authorities | (2 | ) |
Balance at March 31, 2016 | $ | 147 |
|
In the next twelve months, Ashland expects a decrease in the amount accrued for uncertain tax positions of up to $3 million for continuing operations and $1 million for discontinued operations related primarily to audit settlements and statute of limitations expirations in various tax jurisdictions. It is reasonably possible that there could be other material changes to the amount of uncertain tax positions due to activities of the taxing authorities, settlement of audit issues or the reassessment of existing uncertain tax positions; however, Ashland is not able to estimate the impact of these items at this time.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE J – INCOME TAXES (continued)
On September 22, 2015, Ashland announced that the Board of Directors approved proceeding with a plan to separate Ashland into two independent, publicly traded companies comprising of the new Ashland and Valvoline. Ashland intends for the separation to be tax free for Ashland shareholders; however, there could be material one-time tax costs incurred by Ashland associated with internal restructuring steps that will be recorded in subsequent quarters when the plans are finalized.
Other matters
During the March 2015 quarter, Ashland received funds as a result of a tax indemnity settlement. As a result, Ashland recognized $16 million of income during the three months ended March 31, 2015 within selling, general and administrative expenses in the Statements of Consolidated Comprehensive Income.
NOTE K – EMPLOYEE BENEFIT PLANS
For the six months ended March 31, 2016, Ashland contributed $8 million to its non-qualified U.S. pension plans and $7 million to its non-U.S. pension plans. No contributions were made to Ashland's qualified U.S. pension plans during the six months ended March 31, 2016. Ashland expects to make additional contributions to the non-qualified U.S. plans of approximately $7 million and to the non-U.S. plans of approximately $8 million during the remainder of 2016.
Plan Amendments and Remeasurements
During March 2016, Ashland announced plans to amend the majority of its U.S. pension plans, with the exception of certain union plans, to freeze the accrual of pension benefits for participants. The freezing of pension benefits will be effective September 30, 2016. Additionally, Ashland announced that it will reduce retiree life and medical benefits effective October 1, 2016 and January 1, 2017, respectively. The net effect of the current quarter remeasurements resulted in a loss of $23 million within the Statements of Consolidated Comprehensive Income for the three and six months ended March 31, 2016. The following details the components of the remeasurement impact:
| |
• | As a result of the remeasurement the affected U.S. pension plans, Ashland recognized a curtailment gain of $65 million and actuarial loss of $123 million during the three and six months ended March 31, 2016. |
| |
• | As a result of the remeasurement of other postretirement benefit plans, Ashland recognized a curtailment gain of $39 million and actuarial loss of $7 million during the three and six months ended March 31, 2016. This remeasurement reduced the benefit obligations by $86 million, which will be amortized to income in future periods. |
| |
• | Ashland was also required to remeasure a non-U.S. pension plan during the quarter and as a result recognized a curtailment gain of $6 million and actuarial loss of $3 million during the three and six months ended March 31, 2016. |
During the three and six months ended March 31, 2015, Ashland was required to remeasure a non-U.S. pension plan due to the exit of Water Technologies' employees from the plan. As a result of the remeasurement, Ashland recognized a curtailment gain of $7 million and actuarial loss of $11 million during the three and six months ended March 31, 2015. Of these amounts, all of the curtailment gain and $2 million of the actuarial loss were attributable to the Water Technologies business and therefore included in the discontinued operations caption of the Statements of Consolidated Comprehensive Income for the three and six months ended March 31, 2015.
For segment reporting purposes, service cost for continuing operations is proportionately allocated to each segment, excluding the Unallocated and other segment, while all other costs for continuing operations are recorded within the Unallocated and other segment.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE K – EMPLOYEE BENEFIT PLANS (continued)
Components of net periodic benefit costs (income)
The following table details the components of pension and other postretirement benefit costs.
|
| | | | | | | | | | | | | | | |
| | | | | Other postretirement |
| Pension benefits | | benefits |
(In millions) | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
Three months ended March 31 | | | | | | | |
Service cost (a) | $ | 6 |
| | $ | 6 |
| | $ | — |
| | $ | — |
|
Interest cost | 31 |
| | 44 |
| | 1 |
| | 2 |
|
Expected return on plan assets | (48 | ) | | (55 | ) | | — |
| | — |
|
Amortization of prior service credit (a) | — |
| | (1 | ) | | (4 | ) | | (4 | ) |
Curtailment | (71 | ) | | (7 | ) | | (39 | ) | | — |
|
Actuarial loss | 126 |
| | 11 |
| | 7 |
| | — |
|
| $ | 44 |
| | $ | (2 | ) | | $ | (35 | ) | | $ | (2 | ) |
| | | | | | | |
Six months ended March 31 | |
| | |
| | |
| | |
|
Service cost (a) | $ | 13 |
| | $ | 13 |
| | $ | — |
| | $ | 1 |
|
Interest cost | 62 |
| | 88 |
| | 3 |
| | 3 |
|
Expected return on plan assets | (96 | ) | | (109 | ) | | — |
| | — |
|
Amortization of prior service credit | (1 | ) | | (1 | ) | | (8 | ) | | (8 | ) |
Curtailment | (71 | ) | | (7 | ) | | (39 | ) | | — |
|
Actuarial loss | 126 |
| | 11 |
| | 7 |
| | — |
|
| $ | 33 |
| | $ | (5 | ) | | $ | (37 | ) | | $ | (4 | ) |
| | | | | | | |
| |
(a) | Activity of $0 denote values less than $1 million. |
Change in Applying Discount Rate to Measure Benefit Costs
During the three months ended December 31, 2015, Ashland changed the method used to estimate the service and interest cost components of net periodic benefit cost for pension and other postretirement benefits. This change compared to the previous method resulted in a decrease in the service and interest cost components for pension and other postretirement benefit costs during the quarter. Historically, Ashland estimated these service and interest cost components utilizing a single weighted-average discount rate derived from the yield curve used to measure the benefit obligation at the beginning of the period. Ashland has elected to utilize a full yield curve approach in the estimation of these components by applying the specific spot rates along the yield curve used in the determination of the benefit obligation to the relevant projected cash flows. Ashland has made this change to provide a more precise measurement of service and interest costs by improving the correlation between projected benefit cash flows to the corresponding spot yield curve rates. This change does not affect the measurement of Ashland's total benefit obligations or annual net periodic benefit costs as the change in the service and interest costs will be offset in the actuarial gain or loss reported, which typically occurs during the fourth fiscal quarter. Ashland has accounted for this change as a change in accounting estimate that is inseparable from a change in accounting principle and accordingly has accounted for it prospectively.
The impact of this discount rate change compared to the previous method will decrease estimated pension and other postretirement benefits service and interest cost by approximately $33 million for the full year 2016. The decrease during the three and six months ended March 31, 2016 was approximately $8 million and $16 million, respectively, with substantially all of the decrease attributable to interest cost. The impact on service cost is not significant due to the nature of Ashland’s largest U.S. pension plan, which is closed to new entrants and has curtailed other benefits. Of this expected annual decrease and based on plan demographics,
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE K – EMPLOYEE BENEFIT PLANS (continued)
approximately $13 million will be reported in cost of sales and approximately $20 million will be reported in selling, general, and administrative expense on a full year basis, or approximately $3 million and $5 million on a quarterly basis, respectively, within the Statements of Consolidated Comprehensive Income in the Unallocated and other segment. Service and interest cost, as well as the other components of net periodic benefit costs, are subject to change for such reasons as an event requiring a remeasurement. Ashland's total projected benefit obligations will not be impacted by these reductions in service and interest costs as the decrease will be substantially offset within the actuarial gain or loss caption when the plans are remeasured during the fiscal year.
NOTE L – LITIGATION, CLAIMS AND CONTIGENCIES
Asbestos litigation
Ashland and Hercules, a wholly-owned subsidiary of Ashland that was acquired in 2009, have liabilities from claims alleging personal injury caused by exposure to asbestos. To assist in developing and annually updating independent reserve estimates for future asbestos claims and related costs given various assumptions, Ashland retained Hamilton, Rabinovitz & Associates, Inc. (HR&A). The methodology used by HR&A to project future asbestos costs is based largely on recent experience, including claim-filing and settlement rates, disease mix, enacted legislation, open claims and litigation defense. The claim experience of Ashland and Hercules are separately compared to the results of previously conducted third party epidemiological studies estimating the number of people likely to develop asbestos-related diseases. Those studies were undertaken in connection with national analyses of the population expected to have been exposed to asbestos. Using that information, HR&A estimates a range of the number of future claims that may be filed, as well as the related costs that may be incurred in resolving those claims. Changes in asbestos-related liabilities and receivables are recorded on an after-tax basis within the discontinued operations caption in the Statements of Consolidated Comprehensive Income.
Ashland asbestos-related litigation
The claims alleging personal injury caused by exposure to asbestos asserted against Ashland result primarily from indemnification obligations undertaken in 1990 in connection with the sale of Riley, a former subsidiary. The amount and timing of settlements and number of open claims can fluctuate from period to period. A summary of Ashland asbestos claims activity, excluding Hercules claims, follows.
|
| | | | | | | | | | | | | | |
| Six months ended | | | | | | |
| March 31 | | Years ended September 30 |
(In thousands) | 2016 |
| | 2015 |
| | 2015 |
| | 2014 |
| | 2013 |
|
Open claims - beginning of period | 60 |
| | 65 |
| | 65 |
| | 65 |
| | 66 |
|
New claims filed | 1 |
| | 1 |
| | 2 |
| | 2 |
| | 2 |
|
Claims settled | — |
| | — |
| | — |
| | (1 | ) | | (1 | ) |
Claims dismissed | (3 | ) | | (1 | ) | | (7 | ) | | (1 | ) | | (2 | ) |
Open claims - end of period | 58 |
| | 65 |
| | 60 |
| | 65 |
| | 65 |
|
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE L – LITIGATION, CLAIMS AND CONTINGENCIES (continued)
Ashland asbestos-related liability
From the range of estimates, Ashland records the amount it believes to be the best estimate of future payments for litigation defense and claim settlement costs, which generally approximates the mid-point of the estimated range of exposure from model results. Ashland reviews this estimate and related assumptions quarterly and annually updates the results of a non-inflated, non-discounted approximate 50-year model developed with the assistance of HR&A. As a result of the most recent annual update of this estimate, completed during the June 2015 quarter, it was determined that the liability total for asbestos claims did not need to be adjusted. Total reserves for asbestos claims were $392 million at March 31, 2016 compared to $409 million at September 30, 2015.
A progression of activity in the asbestos reserve is presented in the following table.
|
| | | | | | | | | | | | | | | | | | | |
| Six months ended | | | | | | |
| March 31 | | Years ended September 30 |
(In millions) | 2016 |
| | 2015 |
| | 2015 |
| | 2014 |
| | 2013 |
|
Asbestos reserve - beginning of period | $ | 409 |
| | $ | 438 |
| | $ | 438 |
| | $ | 463 |
| | $ | 522 |
|
Reserve adjustment | — |
| | — |
| | — |
| | 4 |
| | (28 | ) |
Amounts paid | (17 | ) | | (16 | ) | | (29 | ) | | (29 | ) | | (31 | ) |
Asbestos reserve - end of period | $ | 392 |
| | $ | 422 |
| | $ | 409 |
| | $ | 438 |
| | $ | 463 |
|
Ashland asbestos-related receivables
Ashland has insurance coverage for certain litigation defense and claim settlement costs incurred in connection with its asbestos claims, and coverage-in-place agreements exist with the insurance companies that provide substantially all of the coverage that will be accessed.
For the Ashland asbestos-related obligations, Ashland has estimated the value of probable insurance recoveries associated with its asbestos reserve based on management’s interpretations and estimates surrounding the available or applicable insurance coverage, including an assumption that all solvent insurance carriers remain solvent. Substantially all of the estimated receivables from insurance companies are expected to be due from domestic insurers, all of which are solvent.
In October 2012, Ashland and Hercules initiated various arbitration proceedings against Underwriters at Lloyd’s, certain London companies and/or Chartis (AIG) member companies seeking to enforce these insurers’ contractual obligations to provide indemnity for asbestos liabilities and defense costs under existing coverage-in-place agreements. In addition, Ashland and Hercules initiated a lawsuit in Kentucky state court against certain Berkshire Hathaway entities (National Indemnity Company and Resolute Management, Inc.) on grounds that these Berkshire Hathaway entities had wrongfully interfered with Underwriters’ and Chartis’ performance of their respective contractual obligations to provide asbestos coverage by directing the insurers to reduce and delay certain claim payments.
On January 13, 2015, Ashland and Hercules entered into a comprehensive settlement agreement related to certain insurance coverage for asbestos bodily injury claims with Underwriters at Lloyd’s, certain London companies and Chartis (AIG) member companies, along with National Indemnity Company and Resolute Management, Inc., under which Ashland and Hercules received a total of $398 million. In exchange, all claims were released against these entities for past, present and future coverage obligations arising out of the asbestos coverage-in-place agreements that were the subject of the pending arbitration proceedings. In addition, as part of this settlement, Ashland and Hercules released all claims against National Indemnity Company and Resolute Management, Inc. in the Kentucky state court action. As a result, the arbitration proceedings and the Kentucky state court action have been terminated.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE L – LITIGATION, CLAIMS AND CONTINGENCIES (continued)
As a result of this settlement, Ashland recorded an after-tax gain of $120 million within the discontinued operations caption of the Statements of Consolidated Comprehensive Income during the March 2015 quarter. The Ashland insurance receivable balance was also reduced as a result of this settlement by $227 million within the Condensed Consolidated Balance Sheets.
In addition, during 2015, Ashland placed $335 million of the settlement funds received into a renewable annual trust restricted for the purpose of paying for ongoing and future litigation defense and claim settlement costs incurred in conjunction with asbestos claims.
At March 31, 2016, Ashland’s receivable for recoveries of litigation defense and claim settlement costs from insurers amounted to $139 million, of which $7 million relates to costs previously paid. Receivables from insurers amounted to $150 million at September 30, 2015. During the June 2015 quarter, the annual update of the model used for purposes of valuing the asbestos reserve and its impact on valuation of future recoveries from insurers was completed. This model update resulted in a $3 million decrease in the receivable for probable insurance recoveries.
During the March 2016 quarter, Ashland entered into settlement agreements totaling $4 million with certain insurers, which resulted in a reduction of the Ashland insurance receivable within the Condensed Consolidated Balance Sheets by the same amount.
A progression of activity in the Ashland insurance receivable is presented in the following table.
|
| | | | | | | | | | | | | | | | | | | |
| Six months ended | | | | | | |
| March 31 | | Years ended September 30 |
(In millions) | 2016 |
| | 2015 |
| | 2015 |
| | 2014 |
| | 2013 |
|
Insurance receivable - beginning of period | $ | 150 |
| | $ | 402 |
| | $ | 402 |
| | $ | 408 |
| | $ | 423 |
|
Receivable adjustment | — |
| | — |
| | (3 | ) | | 22 |
| | (3 | ) |
Insurance settlement | (4 | ) | | (227 | ) | | (227 | ) | | — |
| | — |
|
Amounts collected | (7 | ) | | (13 | ) | | (22 | ) | | (28 | ) | | (12 | ) |
Insurance receivable - end of period | $ | 139 |
| | $ | 162 |
| | $ | 150 |
| | $ | 402 |
| | $ | 408 |
|
Hercules asbestos-related litigation
Hercules has liabilities from claims alleging personal injury caused by exposure to asbestos. Such claims typically arise from alleged exposure to asbestos fibers from resin encapsulated pipe and tank products which were sold by one of Hercules’ former subsidiaries to a limited industrial market. The amount and timing of settlements and number of open claims can fluctuate from period to period. A summary of Hercules’ asbestos claims activity follows.
|
| | | | | | | | | | | | | | |
| Six months ended | | | | | | |
| March 31 | | Years ended September 30 |
(In thousands) | 2016 |
| | 2015 |
| | 2015 |
| | 2014 |
| | 2013 |
|
Open claims - beginning of period | 20 |
| | 21 |
| | 21 |
| | 21 |
| | 21 |
|
New claims filed | 1 |
| | 1 |
| | 1 |
| | 1 |
| | 1 |
|
Claims dismissed | (1 | ) | | (1 | ) | | (2 | ) | | (1 | ) | | (1 | ) |
Open claims - end of period | 20 |
| | 21 |
| | 20 |
| | 21 |
| | 21 |
|
Hercules asbestos-related liability
From the range of estimates, Ashland records the amount it believes to be the best estimate of future payments for litigation defense and claim settlement costs, which generally approximates the mid-point of the estimated
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE L – LITIGATION, CLAIMS AND CONTINGENCIES (continued)
range of exposure from model results. Ashland reviews this estimate and related assumptions quarterly and annually updates the results of a non-inflated, non-discounted approximate 50-year model developed with the assistance of HR&A. As a result of the most recent annual update of this estimate, completed during the June 2015 quarter, it was determined that the liability for Hercules asbestos-related claims should be increased by $4 million. Total reserves for asbestos claims were $303 million at March 31, 2016 compared to $311 million at September 30, 2015.
A progression of activity in the asbestos reserve is presented in the following table.
|
| | | | | | | | | | | | | | | | | | | |
| Six months ended | | | | | | |
| March 31 | | Years ended September 30 |
(In millions) | 2016 |
| | 2015 |
| | 2015 |
| | 2014 |
| | 2013 |
|
Asbestos reserve - beginning of period | $ | 311 |
| | $ | 329 |
| | $ | 329 |
| | $ | 342 |
| | $ | 320 |
|
Reserve adjustment | — |
| | — |
| | 4 |
| | 10 |
| | 46 |
|
Amounts paid | (8 | ) | | (9 | ) | | (22 | ) | | (23 | ) | | (24 | ) |
Asbestos reserve - end of period | $ | 303 |
| | $ | 320 |
| | $ | 311 |
| | $ | 329 |
| | $ | 342 |
|
Hercules asbestos-related receivables
For the Hercules asbestos-related obligations, certain reimbursement obligations pursuant to coverage-in-place agreements with insurance carriers exist. As a result, any increases in the asbestos reserve have been partially offset by probable insurance recoveries. Ashland has estimated the value of probable insurance recoveries associated with its asbestos reserve based on management’s interpretations and estimates surrounding the available or applicable insurance coverage, including an assumption that all solvent insurance carriers remain solvent. The estimated receivable consists exclusively of solvent domestic insurers.
As of March 31, 2016 and September 30, 2015, the receivables from insurers amounted to $56 million. During the June 2015 quarter, the annual update of the model used for purposes of valuing the asbestos reserve and its impact on valuation of future recoveries from insurers was completed. This model update resulted in a $1 million increase in the receivable for probable insurance recoveries.
As a result of the January 2015 asbestos insurance settlement previously described, Hercules has resolved all disputes with Chartis (AIG) member companies under their existing coverage-in-place agreement for past, present and future Hercules asbestos claims. As a result, during the March 2015 quarter, a $22 million reduction in the insurance receivable balance within the Condensed Consolidated Balance Sheets was recorded.
A progression of activity in the Hercules insurance receivable is presented in the following table.
|
| | | | | | | | | | | | | | | | | | | |
| Six months ended | | | | | | |
| March 31 | | Years ended September 30 |
(In millions) | 2016 |
| | 2015 |
| | 2015 |
| | 2014 |
| | 2013 |
|
Insurance receivable - beginning of period | $ | 56 |
| | $ | 77 |
| | $ | 77 |
| | $ | 75 |
| | $ | 56 |
|
Receivable adjustment | — |
| | — |
| | 1 |
| | 3 |
| | 19 |
|
Insurance settlement | — |
| | (22 | ) | | (22 | ) | | — |
| | — |
|
Amounts collected | — |
| | — |
| | — |
| | (1 | ) | | — |
|
Insurance receivable - end of period | $ | 56 |
| | $ | 55 |
| | $ | 56 |
| | $ | 77 |
| | $ | 75 |
|
Asbestos litigation cost projection
Projecting future asbestos costs is subject to numerous variables that are extremely difficult to predict. In addition to the significant uncertainties surrounding the number of claims that might be received, other variables
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE L – LITIGATION, CLAIMS AND CONTINGENCIES (continued)
include the type and severity of the disease alleged by each claimant, the long latency period associated with asbestos exposure, mortality rates, dismissal rates, costs of medical treatment, the impact of bankruptcies of other companies that are co-defendants in claims, uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case, and the impact of potential changes in legislative or judicial standards. Furthermore, any predictions with respect to these variables are subject to even greater uncertainty as the projection period lengthens. In light of these inherent uncertainties, Ashland believes that the asbestos reserves for Ashland and Hercules represent the best estimate within a range of possible outcomes. As a part of the process to develop these estimates of future asbestos costs, a range of long-term cost models was developed. These models are based on national studies that predict the number of people likely to develop asbestos-related diseases and are heavily influenced by assumptions regarding long-term inflation rates for indemnity payments and legal defense costs, as well as other variables mentioned previously. Ashland has currently estimated in various models ranging from approximately 40 to 50 year periods that it is reasonably possible that total future litigation defense and claim settlement costs on an inflated and undiscounted basis could range as high as approximately $880 million for the Ashland asbestos-related litigation (current reserve of $392 million) and approximately $560 million for the Hercules asbestos-related litigation (current reserve of $303 million), depending on the combination of assumptions selected in the various models. If actual experience is worse than projected, relative to the number of claims filed, the severity of alleged disease associated with those claims or costs incurred to resolve those claims, or actuarial refinements or improvements to the assumptions used within these models are initiated, Ashland may need to further increase the estimates of the costs associated with asbestos claims and these increases could be material over time.
Environmental remediation and asset retirement obligations
Ashland is subject to various federal, state and local environmental laws and regulations that require environmental assessment or remediation efforts (collectively environmental remediation) at multiple locations. At March 31, 2016, such locations included 84 waste treatment or disposal sites where Ashland has been identified as a potentially responsible party under Superfund or similar state laws, 133 current and former operating facilities (including certain operating facilities conveyed to Marathon Ashland Petroleum LLC (MAP) in 2005) and about 1,225 service station properties, of which 63 are being actively remediated.
Ashland’s reserves for environmental remediation and related environmental litigation amounted to $176 million at March 31, 2016 compared to $186 million at September 30, 2015, of which $130 million at March 31, 2016 and $139 million at September 30, 2015 were classified in other noncurrent liabilities on the Condensed Consolidated Balance Sheets.
The following table provides a reconciliation of the changes in the environmental remediation reserves during the six months ended March 31, 2016 and 2015.
|
| | | | | | | |
| Six months ended |
| March 31 |
(In millions) | 2016 |
| | 2015 |
|
Reserve - beginning of period | $ | 186 |
| | $ | 197 |
|
Disbursements | (24 | ) | | (22 | ) |
Revised obligation estimates and accretion | 14 |
| | 15 |
|
Reserve - end of period | $ | 176 |
| | $ | 190 |
|
The total reserves for environmental remediation reflect Ashland’s estimates of the most likely costs that will be incurred over an extended period to remediate identified conditions for which the costs are reasonably estimable, without regard to any third-party recoveries. Engineering studies, probability techniques, historical experience and other factors are used to identify and evaluate remediation alternatives and their related costs
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE L – LITIGATION, CLAIMS AND CONTINGENCIES (continued)
in determining the estimated reserves for environmental remediation. Ashland continues to discount certain environmental sites and regularly adjusts its reserves as environmental remediation continues. Ashland has estimated the value of its probable insurance recoveries associated with its environmental reserve based on management’s interpretations and estimates surrounding the available or applicable insurance coverage. At March 31, 2016 and September 30, 2015, Ashland’s recorded receivable for these probable insurance recoveries was $22 million and $23 million, respectively, of which $15 million at March 31, 2016 and $16 million at September 30, 2015 were classified in other noncurrent assets on the Condensed Consolidated Balance Sheets.
Components of environmental remediation expense included within the selling, general and administrative expense caption of the Statements of Consolidated Comprehensive Income are presented in the following table for the three and six months ended March 31, 2016 and 2015.
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31 | | March 31 |
(In millions) | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
Environmental expense | $ | 9 |
| | $ | 9 |
| | $ | 13 |
| | $ | 14 |
|
Accretion (a) | 1 |
| | — |
| | 1 |
| | 1 |
|
Legal expense | 3 |
| | 2 |
| | 5 |
| | 3 |
|
Total expense | 13 |
| | 11 |
| | 19 |
| | 18 |
|
| | | | | | | |
Insurance receivable | (1 | ) | | (1 | ) | | (1 | ) | | (1 | ) |
Total expense, net of receivable activity | $ | 12 |
| | $ | 10 |
| | $ | 18 |
| | $ | 17 |
|
| | | | | | | |
| |
(a) | Activity of $0 denotes value less than $1 million. |
Environmental remediation reserves are subject to numerous inherent uncertainties that affect Ashland’s ability to estimate its share of the costs. Such uncertainties involve the nature and extent of contamination at each site, the extent of required cleanup efforts under existing environmental regulations, widely varying costs of alternate cleanup methods, changes in environmental regulations, the potential effect of continuing improvements in remediation technology, and the number and financial strength of other potentially responsible parties at multiparty sites. Although it is not possible to predict with certainty the ultimate costs of environmental remediation, Ashland currently estimates that the upper end of the reasonably possible range of future costs for identified sites could be as high as approximately $375 million. No individual remediation location is significant, as the largest reserve for any site is 15% or less of the remediation reserve.
Other legal proceedings and claims
In addition to the matters described above, there are other various claims, lawsuits and administrative proceedings pending or threatened against Ashland and its current and former subsidiaries. Such actions are with respect to commercial matters, product liability, toxic tort liability, and other environmental matters, which seek remedies or damages, some of which are for substantial amounts. While Ashland cannot predict with certainty the outcome of such actions, it believes that adequate reserves have been recorded and losses already recognized with respect to such actions were immaterial as of March 31, 2016 and September 30, 2015. There is a reasonable possibility that a loss exceeding amounts already recognized may be incurred related to these actions; however, Ashland believes that such potential losses were immaterial as of March 31, 2016.
NOTE M – EARNINGS PER SHARE
The following is the computation of basic and diluted earnings per share (EPS) from continuing operations. Stock appreciation rights (SARs) and warrants available to purchase shares outstanding for each
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE M – EARNINGS PER SHARE (continued)
reporting period whose grant price was greater than the average market price of Ashland Common Stock for each applicable period were not included in the computation of income from continuing operations per diluted share because the effect of these instruments would be antidilutive. The total number of these shares outstanding was approximately 1.2 million and 0.6 million at March 31, 2016 and 2015, respectively. Earnings per share is reported under the treasury stock method.
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31 | | March 31 |
(In millions except per share data) | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
Numerator | | | | | | | |
Numerator for basic and diluted EPS – Income | | | | | | | |
from continuing operations | $ | 87 |
| | $ | 95 |
| | $ | 178 |
| | $ | 136 |
|
Denominator | |
| | |
| | |
| | |
Denominator for basic EPS – Weighted-average | |
| | |
| | |
| | |
common shares outstanding | 62 |
| | 68 |
| | 63 |
| | 69 |
|
Share-based awards convertible to common shares | 1 |
| | 1 |
| | 1 |
| | 1 |
|
Denominator for diluted EPS – Adjusted weighted- | |
| | |
| | |
| | |
average shares and assumed conversions | 63 |
| | 69 |
| | 64 |
| | 70 |
|
| | | | | | | |
EPS from continuing operations | |
| | |
| | |
| | |
|
Basic | $ | 1.39 |
| | $ | 1.40 |
| | $ | 2.79 |
| | $ | 1.97 |
|
Diluted | 1.38 |
| | 1.39 |
| | 2.76 |
| | 1.95 |
|
NOTE N – STOCKHOLDERS’ EQUITY ITEMS
Stock repurchase programs
In April 2015, Ashland's Board of Directors approved a new $1 billion share repurchase authorization that will expire on December 31, 2017 (the 2015 stock repurchase program). This authorization replaced the March 2014 authorization of a $1.35 billion common stock repurchase program (the 2014 stock repurchase program), which was completed during the June 2015 quarter, with delivery of the final shares occurring in July 2015. Under both programs, Ashland’s common shares could be repurchased in open market transactions, privately negotiated transactions or pursuant to one or more accelerated stock repurchase programs or Rule 10b5-1 plans. The following summarizes the stock repurchases under these authorizations.
2015 stock repurchase program agreement
In November 2015, under the 2015 stock repurchase program, Ashland announced that it entered into an accelerated share repurchase agreement (2016 ASR Agreement) with Goldman, Sachs & Co. Under the 2016 ASR Agreement, Ashland paid an initial purchase price of $500 million and received an initial delivery of approximately 3.9 million shares of common stock during November 2015. In February 2016, Goldman, Sachs & Co. exercised their early termination option under the 2016 ASR Agreement and the pricing period was closed. The settlement price, which represents the weighted average price of Ashland's common stock over the pricing period less a discount, was $99.01 per share. Based on this settlement price, the final number of shares repurchased by Ashland that were delivered by Goldman, Sachs, and Co. under the 2016 ASR Agreement was 5.1 million shares. Ashland received the additional 1.2 million shares during the three months ended March 31, 2016 to settle the difference between the initial share delivery and the total number of shares repurchased.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE N – STOCKHOLDERS' EQUITY ITEMS (continued)
2014 stock repurchase program agreements
The following stock repurchase agreements were entered into as part of the previous $1.35 billion common stock repurchase program.
| |
• | In 2014, completed a prepaid variable share repurchase agreement for $80 million and received 0.8 million shares. |
| |
• | In 2014, entered into $750 million of accelerated share repurchase agreements that were completed during the June 2015 quarter and received 6.4 million shares, of which 0.5 million shares were received during July 2015. |
| |
• | In 2014, entered into $250 million of share repurchase agreements that were completed during the December 2014 quarter and received 2.4 million shares, of which 1.2 million were repurchased during the December 2014 quarter. |
| |
• | In 2015, entered into $270 million of accelerated share repurchase agreements that were completed during the June 2015 quarter and received 2.2 million shares, of which 0.3 million shares were received during July 2015. |
Stockholder dividends
In May 2015, the Board of Directors of Ashland announced a quarterly cash dividend increase to 39 cents per share to eligible shareholders of record. This amount was paid for quarterly dividends in the first and second quarters of fiscal 2016 and the third and fourth quarters of fiscal 2015, and was an increase from the quarterly cash dividend of 34 cents per share paid during the first and second quarters of fiscal 2015.
Accumulated other comprehensive income (loss)
Components of other comprehensive income (loss) recorded in the Statements of Consolidated Comprehensive Income are presented below, before tax and net of tax effects.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE N – STOCKHOLDERS' EQUITY ITEMS (continued)
|
| | | | | | | | | | | | | | | | | | | | | | | |
| 2016 | | 2015 |
| | | Tax |
| | | | | | Tax |
| | |
| Before |
| | (expense) |
| | Net of |
| | Before |
| | (expense) |
| | Net of |
|
(In millions) | tax |
| | benefit |
| | tax |
| | tax |
| | benefit |
| | tax |
|
Three months ended March 31 | | | | | | | | | | | |
Other comprehensive income (loss) | | | | | | | | | | | |
Unrealized translation gain (loss) | $ | 80 |
| | $ | — |
| | $ | 80 |
| | $ | (256 | ) | | $ | 1 |
| | $ | (255 | ) |
Pension and postretirement obligation adjustment: | | | | | | | | | | | |
Adjustment of unrecognized prior service credit | 86 |
| | (31 | ) | | 55 |
| | — |
| | — |
| | — |
|
Amortization of unrecognized prior service | | | | | | | | | | | |
credits included in net income (a) | (45 | ) | | 14 |
| | (31 | ) | | (8 | ) | | 2 |
| | (6 | ) |
Unrealized gain on available-for-sale securities | 5 |
| | (2 | ) | | 3 |
| | — |
| | — |
| | — |
|
Total other comprehensive income (loss) | $ | 126 |
| | $ | (19 | ) | | $ | 107 |
| | $ | (264 | ) | | $ | 3 |
| | $ | (261 | ) |
| | | | | | | | | | | |
Six months ended March 31 | | | | | | | | | | | |
Other comprehensive income (loss) | | | | | | | | | | | |
Unrealized translation gain (loss) | $ | 17 |
| | $ | 2 |
| | $ | 19 |
| | $ | (382 | ) | | $ | — |
| | $ | (382 | ) |
Pension and postretirement obligation adjustment: | | | | | | | | | | | |
Adjustment of unrecognized prior service credit | 86 |
| | (31 | ) | | 55 |
| | — |
| | — |
| | — |
|
Amortization of unrecognized prior service | | | | | | | | | | | |
credits included in net income (a) | (49 | ) | | 15 |
| | (34 | ) | | (12 | ) | | 1 |
| | (11 | ) |
Unrealized gain on available-for-sale securities | 14 |
| | (5 | ) | | 9 |
| | — |
| | — |
| | — |
|
Total other comprehensive income (loss) | $ | 68 |
| | $ | (19 | ) | | $ | 49 |
| | $ | (394 | ) | | $ | 1 |
| | $ | (393 | ) |
| | | | | | | | | | | |
| |
(a) | Amortization of unrecognized prior service credits are included in the calculation of net periodic benefit costs (income) for pension and other postretirement plans. For specific financial statement captions impacted by the amortization see the table below. |
In accordance with U.S. GAAP, as discussed in the table above, certain pension and postretirement costs (income) are amortized from accumulated other comprehensive income and recognized in net income. The captions on the Statements of Consolidated Comprehensive Income impacted by the amortization of unrecognized prior service credits for pension and other postretirement plans are disclosed within. During the three and six months ended March 31, 2016, the amortization of unrecognized prior service credits includes the impact of the pension and other postretirement plan remeasurements of $40 million. See Note K for more information.
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31 | | March 31 |
(In millions) | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
Cost of sales | $ | (18 | ) | | $ | (2 | ) | | $ | (20 | ) | | $ | (3 | ) |
Selling, general and administrative expense | (27 | ) | | (3 | ) | | (29 | ) | | (6 | ) |
Discontinued operations | — |
| | (3 | ) | | — |
| | (3 | ) |
Total amortization of unrecognized prior service credits | $ | (45 | ) | | $ | (8 | ) | | $ | (49 | ) | | $ | (12 | ) |
NOTE O – STOCK INCENTIVE PLANS
Ashland has stock incentive plans under which key employees or directors are granted stock-settled SARs, performance share awards or nonvested stock awards. Each program is typically a long-term incentive plan
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE O – STOCK INCENTIVE PLANS (continued)
designed to link employee compensation with increased shareholder value or reward superior performance and encourage continued employment with Ashland. Ashland recognizes compensation expense for the grant date fair value of stock-based awards over the applicable vesting period within the selling, general and administrative expense caption of the Statements of Consolidated Comprehensive Income. Stock-based compensation expense was $8 million for the three months ended March 31, 2016 and 2015. For the six months ended March 31, 2016 and 2015, stock-based compensation expense was $18 million and $23 million, respectively. Included within expense during the six months ended March 31, 2016 and 2015 were $1 million of cash-settled restricted stock awards. In addition, a $7 million award modification within performance shares was designated as a cash item during the six months ended March 31, 2015.
SARs
SARs are granted to employees or directors at a price equal to the fair market value of the stock on the date of grant and typically become exercisable over periods of one to three years. Unexercised SARs lapse ten years and one month after the date of grant. SARs granted for the three months ended March 31, 2015 were 0.05 million. No SARS were granted for the three months ended March 31, 2016. SARs granted for the six months ended March 31, 2016 and 2015 were 0.4 million and 0.3 million, respectively. As of March 31, 2016, there was $12 million of total unrecognized compensation costs related to SARs. That cost is expected to be recognized over a weighted-average period of 2.1 years. Ashland estimates the fair value of SARs granted using the Black-Scholes option-pricing model. This model requires several assumptions, which Ashland has developed and updates based on historical trends and current market observations. The accuracy of these assumptions is critical to the estimate of fair value for these equity instruments.
Nonvested stock awards
Nonvested stock awards are granted to employees or directors at a price equal to the fair market value of the stock on the date of grant and generally vest over a one-to-five-year period. During 2016, these awards were granted as stock units that will convert to shares upon vesting, while the grants in prior years were made in shares. These awards are subject to forfeiture upon termination of service before the vesting period ends. Only nonvested stock awards granted in the form of shares entitle employees or directors to vote the shares. Dividends on nonvested stock awards granted are in the form of additional units or shares of nonvested stock awards, which are subject to vesting and forfeiture provisions. Nonvested stock awards granted were 6,100 and 62,850 for the three months ended March 31, 2016 and 2015, respectively. Nonvested stock awards granted were 92,950 and 167,600 for the six months ended March 31, 2016 and 2015, respectively. As of March 31, 2016, there was $17 million of total unrecognized compensation costs related to nonvested stock awards. That cost is expected to be recognized over a weighted-average period of 1.6 years.
Performance shares
Ashland sponsors a long-term incentive plan that awards performance shares/units to certain key employees that are tied to Ashland’s overall financial performance relative to the financial performance of selected industry peer groups and/or internal targets. Awards are granted annually, with each award covering a three-year vesting period. Each performance share/unit is convertible to one share of Ashland Common Stock. These plans are recorded as a component of stockholders’ equity in the Condensed Consolidated Balance Sheets. Performance measures used to determine the actual number of performance shares issuable upon vesting include an equal weighting of Ashland’s total shareholder return (TSR) performance and Ashland’s return on investment (ROI) performance as compared to the internal targets. TSR relative to peers is considered a market condition while ROI is considered a performance condition under applicable U.S. GAAP. Nonvested performance shares/units do not entitle employees to vote the shares or to receive any dividends thereon. Performance shares/units granted for the three months ended March 31, 2015 were 21,150. No performance shares/units were granted during the three months ended March 31, 2016. Performance shares/units granted for the six months ended
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE O – STOCK INCENTIVE PLANS (continued)
March 31, 2016 and 2015 were 0.1 million. As of March 31, 2016, there was $12 million of total unrecognized compensation costs related to performance shares/units. That cost is expected to be recognized over a weighted-average period of 2.0 years.
During the December 2014 quarter, Ashland modified certain awards of its performance shares. The awards were modified to provide that the instruments be paid in cash instead of stock. This change in payment designation caused Ashland to recognize $7 million in incremental stock-based compensation expense related to this award modification during the six months ended March 31, 2015.
NOTE P – REPORTABLE SEGMENT INFORMATION
Ashland determines its reportable segments based on how operations are managed internally for the products and services sold to customers, including how the results are reviewed by the chief operating decision maker, which includes determining resource allocation methodologies used for reportable segments. Operating income is the primary measure reviewed by the chief operating decision maker in assessing each reportable segment's financial performance. Ashland does not aggregate operating segments to arrive at these reportable segments. Ashland’s businesses are managed within three reportable segments: Specialty Ingredients, Performance Materials and Valvoline.
Reportable segment business descriptions
Specialty Ingredients is a global leader in cellulose ethers, vinyl pyrrolidones and biofunctionals. It offers industry-leading products, technologies and resources for solving formulation and product-performance challenges. Specialty Ingredients uses natural, synthetic and semisynthetic polymers derived from plant and seed extract, cellulose ethers, vinyl pyrrolidones, acrylic polymers as well as polyester and polyurethane-based adhesives. Specialty Ingredients includes two divisions, Consumer Specialties and Industrial Specialties, that offer comprehensive and innovative solutions for today’s demanding consumer and industrial applications. Key customers include: pharmaceutical companies; makers of personal care products, food and beverages; manufacturers of paint, coatings and construction materials; packaging and converting; and oilfield service companies. During the September 2015 quarter, Ashland sold the industrial biocides assets within Specialty Ingredients. See Note C for information on the divestiture of these assets.
Performance Materials is a global leader in unsaturated polyester resins and vinyl ester resins. The business unit has leading positions in gelcoats, maleic anhydride, butanediol, tetrahydrofuran, N-Methylpyrrolidone and other intermediates and solvents. Key customers include: manufacturers of residential and commercial building products; industrial product specifiers and manufacturers; wind blade and pipe manufacturers; automotive and truck OEM suppliers; boatbuilders; engineered plastics and electronic producers; and specialty chemical manufacturers. Results from the former Elastomers division were included in Performance Materials' results of operations within the Statements of Consolidated Comprehensive Income until its December 1, 2014 sale. See Note C for information on the divestiture of the Elastomers division.
Valvoline is a leading, worldwide producer and distributor of premium-branded automotive, commercial and industrial lubricants and automotive chemicals. It ranks as the #2 quick-lube chain and #3 passenger car motor oil brand in the United States. The brand operates and franchises 1,052 Valvoline Instant Oil ChangeSM centers in the United States. It also markets Valvoline™ lubricants and automotive chemicals; MaxLife™ lubricants created for higher-mileage engines; SynPower™ synthetic motor oil; and Zerex™ antifreeze. Key customers include: retail auto parts stores and mass merchandisers who sell to consumers; installers, such as car dealers, repair shops and quick lubes; commercial fleets; and distributors. During February 2016, Ashland completed the acquisition of Oil Can Henry's resulting in the addition of 89 quick-lube stores. See Note B for information on the acquisition of Oil Can Henry's. During the June 2015 quarter, Ashland sold its Valvoline car care product
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE P – REPORTABLE SEGMENT INFORMATION (continued)
assets, including Car BriteTM and Eagle OneTM automotive appearance products, and sold its joint venture equity investment in Venezuela. See Note C for information on the divestiture of this investment and the car care product assets.
Unallocated and Other generally includes items such as components of pension and other postretirement benefit plan expenses (excluding service costs, which are allocated to the reportable segments), certain significant company-wide restructuring activities, including internal separation costs, and legacy costs or adjustments that relate to divested businesses that are no longer operated by Ashland.
Reportable segment results
Results of Ashland’s reportable segments are presented based on its management structure and internal accounting practices. The structure and practices are specific to Ashland; therefore, the financial results of Ashland’s reportable segments are not necessarily comparable with similar information for other comparable companies. Ashland allocates all costs to its reportable segments except for certain significant company-wide restructuring activities, such as the restructuring plans described in Note E, and other costs or adjustments that generally relate to former businesses that Ashland no longer operates. The service cost component of pension and other postretirement benefits costs is allocated to each reportable segment on a ratable basis; while the remaining components of pension and other postretirement benefits costs are recorded to Unallocated and other. Ashland refines its expense allocation methodologies to the reportable segments from time to time as internal accounting practices are improved, more refined information becomes available and businesses change. Revisions to Ashland’s methodologies that are deemed insignificant are applied on a prospective basis.
The following table presents various financial information for each reportable segment for the three and six months ended March 31, 2016 and 2015.
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31 | | March 31 |
(In millions - unaudited) | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
SALES | | | | | | | |
Specialty Ingredients | $ | 529 |
| | $ | 583 |
| | $ | 1,004 |
| | $ | 1,144 |
|
Performance Materials | 239 |
| | 286 |
| | 470 |
| | 623 |
|
Valvoline | 479 |
| | 481 |
| | 936 |
| | 974 |
|
| $ | 1,247 |
| | $ | 1,350 |
| | $ | 2,410 |
| | $ | 2,741 |
|
OPERATING INCOME (LOSS) | |
| | |
| | |
| | |
|
Specialty Ingredients | $ | 65 |
| | $ | 65 |
| | $ | 103 |
| | $ | 125 |
|
Performance Materials | 20 |
| | 30 |
| | 43 |
| | 55 |
|
Valvoline | 105 |
| | 82 |
| | 197 |
| | 165 |
|
Unallocated and other | (43 | ) | | 16 |
| | (45 | ) | | 17 |
|
| $ | 147 |
| | $ | 193 |
| | $ | 298 |
| | $ | 362 |
|
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
FORWARD-LOOKING STATEMENTS
This Form 10-Q contains forward-looking statements including, without limitation, statements made under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operation” (MD&A), within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Ashland has identified some of these forward-looking statements with words such as “anticipates,” “believes,” “expects,” “estimates,” “is likely,” “predicts,” “projects,” “forecasts,” “objectives,” “may,” “will,” “should,” “plans” and “intends” and the negative of these words or other comparable terminology. These forward-looking statements include statements relating to status of the separation process, the plan to pursue an IPO of up to 20 percent of the common stock of Valvoline and the expected completion of the separation through the subsequent distribution of Valvoline common stock, the expected timing of filing of a registration statement for the registration of common stock of Valvoline in the IPO, the anticipated timing of completion of the planned IPO and subsequent distribution of the remaining Valvoline common stock, and Ashland’s and Valvoline’s expected ratings profiles, capital structures, future financial flexibility and ability to pursue their long-term strategies. In addition, Ashland may from time to time make forward-looking statements in its annual report, quarterly reports and other filings with the Securities and Exchange Commission (SEC), news releases and other written and oral communications. These forward-looking statements are based on Ashland’s expectations and assumptions, as of the date such statements are made, regarding Ashland’s future operating performance and financial condition, including the proposed separation of its specialty chemicals and Valvoline businesses, the proposed IPO of its Valvoline business, the expected timetable for completing the IPO and the separation, the future financial and operating performance of each company, strategic and competitive advantages of each company, the leadership of each company, and future opportunities for each company, as well as the economy and other future events or circumstances. Ashland’s expectations and assumptions include, without limitation, those mentioned within the MD&A, internal forecasts and analyses of current and future market conditions and trends, management plans and strategies, operating efficiencies and economic conditions (such as prices, supply and demand, cost of raw materials, and the ability to recover raw-material cost increases through price increases), and risks and uncertainties associated with the following: the possibility that the proposed IPO or separation will not be consummated within the anticipated time period or at all, including as the result of regulatory, market or other factors; the potential for disruption to Ashland’s business in connection with the proposed IPO or separation; the potential that the new Ashland and Valvoline do not realize all of the expected benefits of the proposed IPO or separation or obtain the expected credit ratings following the proposed IPO or separation; Ashland’s substantial indebtedness (including the possibility that such indebtedness and related restrictive covenants may adversely affect Ashland’s future cash flows, results of operations, financial condition and its ability to repay debt); the impact of acquisitions and/or divestitures Ashland has made or may make (including the possibility that Ashland may not realize the anticipated benefits from such transactions); Ashland’s ability to generate sufficient cash to finance its stock repurchase plans; severe weather, natural disasters, and legal proceedings and claims (including environmental and asbestos matters). Various risks and uncertainties may cause actual results to differ materially from those stated, projected or implied by any forward-looking statements, including, without limitation, risks and uncertainties affecting Ashland that are described in “Use of estimates, risks and uncertainties” in Note A of Notes to Consolidated Financial Statements and in Item 1A in its most recent Form 10-K (including Item 1A Risk Factors) filed with the SEC, which is available on Ashland’s website at http://investor.ashland.com or on the SEC’s website at http://www.sec.gov. Ashland believes its expectations and assumptions are reasonable, but there can be no assurance that the expectations reflected herein will be achieved. Unless legally required, Ashland undertakes no obligation to update any forward-looking statements made in this Form 10-Q whether as a result of new information, future events or otherwise. This Form 10-Q does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale could be unlawful prior to registration or qualification under the securities laws of that jurisdiction.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
The following discussion should be read in conjunction with the Condensed Consolidated Financial Statements and the accompanying Notes to Condensed Consolidated Financial Statements herein.
BUSINESS OVERVIEW
Ashland profile
Ashland is a global leader in differentiated specialty chemicals and, through Valvoline, a premium consumer-branded lubricant supplier. Ashland provides products, services and solutions that meet customers' needs throughout a variety of industries. Ashland’s chemistry is used in a wide variety of markets and applications, including architectural coatings, automotive, construction, energy, food and beverage, personal care and pharmaceutical. With approximately 11,000 employees worldwide, Ashland serves customers in more than 100 countries.
Ashland’s sales generated outside of North America were 47% for the six months ended March 31, 2016 and 2015. Sales by region expressed as a percentage of total consolidated sales for the three and six months ended March 31 were as follows:
|
| | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31 | | March 31 |
Sales by Geography | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
North America (a) | 53 | % | | 52 | % | | 53 | % | | 53 | % |
Europe | 24 | % | | 25 | % | | 24 | % | | 24 | % |
Asia Pacific | 16 | % | | 16 | % | | 16 | % | | 16 | % |
Latin America & other | 7 | % | | 7 | % | | 7 | % | | 7 | % |
| 100 | % | | 100 | % | | 100 | % | | 100 | % |
| | | | | | | |
(a)Ashland includes only U.S. and Canada in its North America designation.
Reportable segments
Ashland’s reporting structure is composed of three reportable segments: Ashland Specialty Ingredients (Specialty Ingredients), Ashland Performance Materials (Performance Materials) and Valvoline. For further descriptions of each reportable segment, see “Results of Operations – Reportable Segment Review” beginning on page 48.
The contribution to sales by each reportable segment expressed as a percentage of total consolidated sales for the three and six months ended March 31 were as follows:
|
| | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31 | | March 31 |
Sales by Reportable Segment | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
Specialty Ingredients | 43 | % | | 43 | % | | 42 | % | | 42 | % |
Performance Materials | 19 | % | | 21 | % | | 19 | % | | 23 | % |
Valvoline | 38 | % | | 36 | % | | 39 | % | | 35 | % |
| 100 | % | | 100 | % | | 100 | % | | 100 | % |
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
KEY DEVELOPMENTS
The following recent transactions and operational decisions had an impact on Ashland’s current and future cash flows, results of operations and financial position.
Ashland Separation of Valvoline
On September 22, 2015, Ashland announced that the Board of Directors approved proceeding with a plan to separate Ashland into two independent, publicly traded companies comprising of the new Ashland and Valvoline. Ashland has continued the process to separate its Valvoline business from its Specialty Ingredients and Performance Materials businesses while it finalizes the transaction structure and obtains customary regulatory and other approvals. Subject to market conditions, Ashland plans to pursue an initial public offering (IPO) of up to 20% of the common stock of Valvoline. Ashland expects to file a registration statement for the common stock of Valvoline with the Securities and Exchange Commission in mid-calendar year 2016 and complete the IPO during the fourth quarter of calendar year 2016. Ashland currently expects that it would distribute the remaining common stock of Valvoline to Ashland's shareholders upon expiration of the IPO lock-up (typically six months after completion of the IPO). Ashland intends for the separation, which is subject to final board approval prior to completion, to be tax free for Ashland shareholders.
The new Ashland will be a global leader in providing specialty chemical solutions to customers in a wide range of consumer and industrial markets. These markets are currently served by Specialty Ingredients and Performance Materials. Key markets and applications include pharmaceutical, personal care, food and beverage, architectural coatings, adhesives, automotive, construction and energy.
Valvoline will focus on building the world's leading engine and automotive maintenance business by providing hands-on expertise to customers in each of its primary market channels: Do-It-Yourself (DIY); Installers; Valvoline Instant Oil ChangeSM; and International.
For the three and six months ended March 31, 2016, Ashland recognized separation costs of $12 million and $18 million, respectively, which are primarily related to consulting and legal fees and employee retention awards. Separation costs are recorded within the selling, general and administrative expense caption of the Statements of Consolidated Comprehensive Income.
Ashland expects to continue to incur certain costs as a result of the separation, including those that are contingent upon the completion of the separation. Ashland intends for the separation to be tax free for Ashland shareholders; however, there could be material one-time tax costs incurred by Ashland associated with internal restructuring steps that will be recorded in subsequent quarters when the plans are finalized. Ashland will recognize these costs when appropriate based on applicable U.S. GAAP requirements.
Stock Repurchase Programs
In April 2015, Ashland's Board of Directors approved a new $1 billion share repurchase authorization, which expires on December 31, 2017, and replaced the March 2014 repurchase program. In November 2015, under this new share repurchase program, Ashland announced that it entered into an accelerated share repurchase agreement (2016 ASR Agreement) with Goldman, Sachs & Co. Under the 2016 ASR Agreement, Ashland paid an initial purchase price of $500 million and received an initial delivery of approximately 3.9 million shares of common stock during November 2015.
In February 2016, Goldman, Sachs & Co. exercised their early termination option under the 2016 ASR Agreement and the pricing period was closed. The settlement price, which represents the weighted average price of Ashland's common stock over the pricing period less a discount, was $99.01 per share. Based on this settlement price, the final number of shares repurchased by Ashland that were delivered by Goldman, Sachs, and Co. under the 2016 ASR Agreement was 5.1 million shares. Ashland received the additional 1.2 million
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
shares during the three months ended March 31, 2016 to settle the difference between the initial share delivery and the total number of shares repurchased.
Pension and Other Postretirement Benefit Plans Amendments and Remeasurements
During March 2016, Ashland announced plans to amend the majority of its U.S. pension plans, with the exception of certain union plans, to freeze the accrual of pension benefits for participants. The freezing of pension benefits will be effective September 30, 2016. Additionally, Ashland announced that it will reduce retiree life and medical benefits effective October 1, 2016 and January 1, 2017, respectively. The net effect of the current quarter remeasurements resulted in a loss of $23 million within the Statements of Consolidated Comprehensive Income for the three and six months ended March 31, 2016. The following details the components of the remeasurement impact:
| |
• | As a result of the remeasurement the affected U.S. pension plans, Ashland recognized a curtailment gain of $65 million and actuarial loss of $123 million during the three and six months ended March 31, 2016. |
| |
• | As a result of the remeasurement of other postretirement benefit plans, Ashland recognized a curtailment gain of $39 million and actuarial loss of $7 million during the three and six months ended March 31, 2016. This remeasurement reduced the benefit obligations by $86 million, which will be amortized to income in future periods. |
| |
• | Ashland was also required to remeasure a non-U.S. pension plan during the quarter and as a result recognized a curtailment gain of $6 million and actuarial loss of $3 million during the three and six months ended March 31, 2016. |
Oil Can Henry's Acquisition
On December 11, 2015, Ashland announced that it signed a definitive agreement to acquire OCH International, Inc. (Oil Can Henry's), which was the 14th largest quick-lube network in the United States, servicing approximately 1 million vehicles annually with 89 quick-lube stores, consisting of 47 company-owned stores and 42 franchise locations, in Oregon, Washington, California, Arizona, Idaho and Colorado. On February 1, 2016, Ashland completed the acquisition.
The acquisition of Oil Can Henry's was valued at $72 million, which included acquired indebtedness of $11 million and other working capital adjustments. Net of acquired indebtedness and certain purchase price adjustments, the net cash outlay was approximately $60 million during the March 2016 quarter. The preliminary purchase price allocation primarily included $82 million of goodwill.
RESULTS OF OPERATIONS – CONSOLIDATED REVIEW
Use of non-GAAP measures
Ashland has included within this document certain non-GAAP measures which include EBITDA (net income (loss), plus income tax expense (benefit), net interest and other financing expenses, and depreciation and amortization), Adjusted EBITDA (EBITDA adjusted for discontinued operations, net gain (loss) on acquisitions and divestitures, other income and (expense) and key items, which may include pro forma effects for significant acquisitions or divestitures, as applicable) and Adjusted EBITDA margin (Adjusted EBITDA, which can include pro forma adjustments, divided by sales). Such measurements are not prepared in accordance with U.S. GAAP and as related to pro forma adjustments, contain Ashland’s best estimates of cost allocations and shared resource costs. Management believes the use of non-GAAP measures on a consolidated and reportable segment basis assists investors in understanding the ongoing operating performance by presenting comparable financial results between periods. The non-GAAP information provided is used by Ashland management and may not be determined in a manner consistent with the methodologies used by other companies. EBITDA and Adjusted EBITDA provide a supplemental presentation of Ashland’s operating performance on a
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
consolidated and reportable segment basis. Adjusted EBITDA generally includes adjustments for unusual, non-operational or restructuring-related activities. In addition, certain financial covenants related to Ashland’s 2015 Senior Credit Agreement are based on similar non-GAAP measures and are defined further in the sections that reference this metric.
In accordance with U.S. GAAP, Ashland recognizes actuarial gains and losses for defined benefit pension and other postretirement benefit plans annually in the fourth quarter of each fiscal year and whenever a plan is determined to qualify for a remeasurement during a fiscal year. Actuarial gains and losses occur when actual experience differs from the estimates used to allocate the change in value of pension and other postretirement benefit plans to expense throughout the year or when assumptions change, as they may each year. Significant factors that can contribute to the recognition of actuarial gains and losses include changes in discount rates used to remeasure pension and other postretirement obligations on an annual basis or upon a qualifying remeasurement, differences between actual and expected returns on plan assets and other changes in actuarial assumptions, such as the life expectancy of plan participants. Management believes Adjusted EBITDA, which includes the expected return on pension plan assets and excludes both the actual return on pension plan assets and the impact of actuarial gains and losses, provides investors with a meaningful supplemental presentation of Ashland’s operating performance. Management believes these actuarial gains and losses are primarily financing activities that are more reflective of changes in current conditions in global financial markets (and in particular interest rates) that are not directly related to the underlying business and that do not have an immediate, corresponding impact on the compensation and benefits provided to eligible employees and retirees. For further information on the actuarial assumptions and plan assets referenced above, see MD&A - Critical Accounting Policies - Employee benefit obligations in the Annual Report on Form 10-K for the fiscal year ended September 30, 2015 and Note K of the Notes to Condensed Consolidated Financial Statements.
Ashland has included free cash flow as an additional non-GAAP metric of cash flow generation. Ashland believes free cash flow is relevant because capital expenditures are an important element of Ashland’s ongoing cash activities. By deducting capital expenditures from operating cash flows, Ashland is able to provide a better indication of the ongoing cash being generated that is ultimately available for both debt and equity holders as well as other investment opportunities.
Consolidated review
Net income
Ashland’s net income is primarily affected by results within operating income, net interest and other financing expense, income taxes, discontinued operations and other significant events or transactions that are unusual or nonrecurring.
Current Quarter - Key financial results for the three months ended March 31, 2016 and 2015 included the following:
| |
• | Ashland’s net income amounted to $87 million and $224 million for the three months ended March 31, 2016 and 2015, respectively, or $1.38 and $3.26 diluted earnings per share, respectively. |
| |
• | Discontinued operations, which are reported net of taxes, resulted in income of $129 million for the three months ended March 31, 2015. The three months ended March 31, 2016 included nominal adjustments, which essentially offset, related to previously divested businesses that qualified as discontinued operations. |
| |
• | Income from continuing operations, which excludes results from discontinued operations, amounted to $87 million and $95 million for the three months ended March 31, 2016 and 2015, respectively, or $1.38 and $1.39 diluted earnings per share, respectively. |
| |
• | The effective income tax expense rates of 15% and 21% for the three months ended March 31, 2016 and 2015, respectively, were both affected by certain discrete items. |
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
| |
• | Ashland incurred pretax net interest and other financing expense of $43 million and $40 million for the three months ended March 31, 2016 and 2015, respectively. |
| |
• | Net loss on divestitures totaled $2 million and $33 million for the three months ended March 31, 2016 and 2015, respectively. |
| |
• | Operating income was $147 million and $193 million for the three months ended March 31, 2016 and 2015, respectively. |
Year-to-Date - Key financial results for six months ended March 31, 2016 and 2015 included the following:
| |
• | Ashland’s net income amounted to $176 million and $257 million for the six months ended March 31, 2016 and 2015, respectively, or $2.73 and $3.68 diluted earnings per share, respectively. |
| |
• | Discontinued operations, which are reported net of taxes, resulted in a loss of $2 million and income of$121 million for the six months ended March 31, 2016 and 2015, respectively. |
| |
• | Income from continuing operations, which excludes results from discontinued operations, amounted to $178 million and $136 million for the six months ended March 31, 2016 and 2015, respectively, or $2.76 and $1.95 diluted earnings per share, respectively. |
| |
• | The effective income tax expense rates of 16% and 17% for the six months ended March 31, 2016 and 2015, respectively, were both affected by certain discrete items. |
| |
• | Ashland incurred pretax net interest and other financing expense of $85 million and $81 million for the six months ended March 31, 2016 and 2015, respectively. |
| |
• | Net loss on divestitures totaled $118 million for the six months ended March 31, 2015. The six months ended March 31, 2016 included nominal adjustments related to previous divestitures, which essentially offset. |
| |
• | Operating income was $298 million and $362 million for the six months ended March 31, 2016 and 2015, respectively. |
For further information on the items reported above, see the discussion in the comparative Statements of Consolidated Comprehensive Income caption review analysis.
Operating income
Current Quarter - Operating income amounted to $147 million and $193 million for the three months ended March 31, 2016 and 2015, respectively. The current and prior year quarters' operating income include certain key items that are excluded to arrive at Adjusted EBITDA. These key items are summarized as follows:
| |
• | $23 million and $9 million of key items related to pension and other postretirement plan remeasurement losses during the three months ended March 31, 2016 and 2015, respectively, with the current quarter key item representing the net impact of a curtailment gain of $110 million related to the current quarter plan amendments and an $133 million actuarial loss due to changes in discount rates and asset values; |
| |
• | $2 million of accelerated depreciation during the three months ended March 31, 2016 and 2015 and $16 million of severance and other costs during the three months ended March 31, 2015 relating to a restructuring plan for a manufacturing facility; |
| |
• | $12 million of costs related to the separation of Valvoline and $4 million of restructuring charges related to office buildings during the three months ended March 31, 2016; |
| |
• | a $14 million impairment related to the Valvoline joint venture equity investment within Venezuela during the three months ended March 31, 2015; |
| |
• | $5 million related to a legal reserve during the three months ended March 31, 2016; and |
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
| |
• | $16 million of tax indemnity income during the three months ended March 31, 2015. |
Operating income for the three months ended March 31, 2016 and 2015 included depreciation and amortization of $83 million (which excluded accelerated depreciation of $2 million for each of the three months ended March 31, 2016 and 2015). EBITDA totaled $228 million and $372 million for the three months ended March 31, 2016 and 2015, respectively. Adjusted EBITDA results in the table below have been prepared to illustrate the ongoing effects of Ashland’s operations, which exclude certain key items, including the net loss on divestitures during the three months ended March 31, 2015.
|
| | | | | | | |
| Three months ended |
| March 31 |
(In millions) | 2016 |
| | 2015 |
|
Net income | $ | 87 |
| | $ | 224 |
|
Income tax expense | 15 |
| | 25 |
|
Net interest and other financing expense | 43 |
| | 40 |
|
Depreciation and amortization (a) | 83 |
| | 83 |
|
EBITDA | 228 |
| | 372 |
|
Income from discontinued operations (net of tax) | — |
| | (129 | ) |
Losses on pension and other postretirement plan remeasurements | 23 |
| | 9 |
|
Restructuring, separation and other costs | 16 |
| | 16 |
|
Legal reserve charge | 5 |
| | — |
|
Accelerated depreciation | 2 |
| | 2 |
|
Net loss on divestitures | — |
| | 33 |
|
Impairment of equity investment | — |
| | 14 |
|
Tax indemnity income | — |
| | (16 | ) |
Adjusted EBITDA | $ | 274 |
| | $ | 301 |
|
| | | |
| |
(a) | Excludes $2 million of accelerated depreciation for each of the three months ended March 31, 2016 and 2015. |
Year-to-Date - Operating income amounted to $298 million and $362 million for the six months ended March 31, 2016 and 2015, respectively. The current and prior year periods' operating income include certain key items that are excluded to arrive at Adjusted EBITDA. In addition to the key items within the current and prior year quarters previously discussed, the following are also excluded on a year-to-date basis:
| |
• | an additional $10 million charge for a legal reserve during the six months ended March 31, 2016; |
| |
• | additional adjustments related to a restructuring plan within an existing manufacturing facility of a $5 million reversal of the previous severance accrual and $2 million of accelerated depreciation during the six months ended March 31, 2016; |
| |
• | an additional $6 million of costs related to the separation of Valvoline during the six months ended March 31, 2016; |
| |
• | a $7 million charge for a stock incentive plan award modification for the six months ended March 31, 2015; and |
•$1 million of global restructuring program costs for the six months ended March 31, 2015.
In addition, during the December 2015 quarter, Ashland elected to change its accounting estimate related to applying discount rates to measure pension and other postretirement benefit costs. The impact of this change had previously been factored into earnings outlooks. See the discussion of Unallocated and other within the "Results of Operations - Reportable Segment Review" section of Management’s Discussion and Analysis
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
herein for further information on this change and its effects on the current period compared to the prior period results.
Operating income for the six months ended March 31, 2016 and 2015 included depreciation and amortization of $164 million and $168 million, respectively (which excluded accelerated depreciation of $4 million and $2 million for the six months ended March 31, 2016 and 2015, respectively). EBITDA totaled $460 million and $533 million for the six months ended March 31, 2016 and 2015, respectively. Adjusted EBITDA results in the table below have been prepared to illustrate the ongoing effects of Ashland’s operations, which exclude certain key items, including the net loss on divestitures during the six months ended March 31, 2015.
|
| | | | | | | |
| Six months ended |
| March 31 |
(In millions) | 2016 |
| | 2015 |
|
Net income | $ | 176 |
| | $ | 257 |
|
Income tax expense | 35 |
| | 27 |
|
Net interest and other financing expense | 85 |
| | 81 |
|
Depreciation and amortization (a) | 164 |
| | 168 |
|
EBITDA | 460 |
| | 533 |
|
Loss (income) from discontinued operations (net of tax) | 2 |
| | (121 | ) |
Losses on pension and other postretirement plan remeasurements | 23 |
| | 9 |
|
Restructuring, separation and other costs, net | 17 |
| | 17 |
|
Legal reserve | 15 |
| | — |
|
Accelerated depreciation | 4 |
| | 2 |
|
Net loss on divestitures | — |
| | 118 |
|
Impairment of equity investment | — |
| | 14 |
|
Tax indemnity income | — |
| | (16 | ) |
Stock incentive award modification | — |
| | 7 |
|
Adjusted EBITDA | $ | 521 |
| | $ | 563 |
|
| | | |
| |
(a) | Excludes $4 million and $2 million of accelerated depreciation for the six months ended March 31, 2016. and 2015, respectively. |
Statements of Consolidated Comprehensive Income – caption review
A comparative analysis of the Statements of Consolidated Comprehensive Income by caption is provided as follows for the three and six months ended March 31, 2016 and 2015.
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31 | | Six months ended March 31 |
(In millions) | 2016 |
| | 2015 |
| | Change |
| | 2016 |
| | 2015 |
| | Change |
|
Sales | $ | 1,247 |
| | $ | 1,350 |
| | $ | (103 | ) | | $ | 2,410 |
| | $ | 2,741 |
| | $ | (331 | ) |
The following table provides a reconciliation of the change in sales between the three and six months ended March 31, 2016 and 2015.
|
| | | | | | | | | |
| Three months ended | | | Six months ended | |
(In millions) | March 31, 2016 | | | March 31, 2016 | |
Pricing | | $ | (70 | ) | | | $ | (139 | ) |
Volume and product mix | | 5 |
| | | (28 | ) |
Currency exchange | | (22 | ) | | | (76 | ) |
Divestitures and acquisitions | | (16 | ) | | | (88 | ) |
Change in sales | | $ | (103 | ) | | | $ | (331 | ) |
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
Current Quarter - Sales for the current quarter decreased $103 million compared to the prior year quarter. Pricing declines and unfavorable currency exchange decreased sales by $70 million, or 5%, and $22 million, or 2%, respectively. Unfavorable foreign currency exchange was primarily due to the U.S. dollar strengthening compared to various foreign currencies. Divestitures of certain divisions and product lines decreased sales by $23 million, or 2%, while the acquisition of Oil Can Henry's within the Valvoline reportable segment increased sales by $7 million. Changes in volume and product mix increased sales by $5 million primarily driven by favorable results within the Valvoline reportable segment which were essentially offset by unfavorable results within the Specialty Ingredients reportable segment. Within Specialty Ingredients, the energy market, which decreased sales by $16 million, negatively impacted the volume results.
Year-to-Date - Sales for the current period decreased $331 million compared to the prior year period. Pricing declines and the net impact of the acquisition and divestitures of certain divisions and product lines resulted in decreased sales of $139 million, or 5%, and $88 million, or 3%, respectively. Unfavorable foreign currency exchange decreased sales by $76 million, or 3%. Changes in volume and product mix decreased sales by $28 million driven by unfavorable results within the Specialty Ingredients reportable segment, primarily due to the energy market which decreased sales by $45 million.
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31 | | Six months ended March 31 |
(In millions) | 2016 |
| | 2015 |
| | Change |
| | 2016 |
| | 2015 |
| | Change |
|
Cost of sales | $ | 823 |
| | $ | 925 |
| | $ | (102 | ) | | $ | 1,595 |
| | $ | 1,906 |
| | $ | (311 | ) |
Gross profit as a percent of sales | 34.0 | % | | 31.5 | % | | |
| | 33.8 | % | | 30.5 | % | | |
|
Fluctuations in cost of sales are driven primarily by raw material prices, volume and changes in product mix, currency exchange, net losses or gains on pension and other postretirement benefit plan remeasurements, and other certain charges incurred as a result of changes or events within the businesses or restructuring activities. The following table provides a quantified reconciliation of the changes in cost of sales between the three and six months ended March 31, 2016 and 2015.
|
| | | | | | | | | |
| Three months ended | | | Six months ended | |
(In millions) | March 31, 2016 | | | March 31, 2016 | |
Changes in: | | | | | |
Production costs | | $ | (58 | ) | | | $ | (133 | ) |
Volume and product mix | | (1 | ) | | | (22 | ) |
Divestitures and acquisitions | | (13 | ) | | | (79 | ) |
Currency exchange | | (15 | ) | | | (54 | ) |
Pension and other postretirement benefit plans expense (income) | | | | | |
(including remeasurements) | | 1 |
| | | (4 | ) |
Severance and other costs | | (16 | ) | | | (21 | ) |
Accelerated depreciation | | — |
| | | 2 |
|
Change in cost of sales | | $ | (102 | ) | |
| $ | (311 | ) |
Current Quarter - Cost of sales for the current quarter decreased $102 million compared to the prior year quarter primarily due to lower production costs, favorable foreign currency exchange, and the net impact of the acquisition and divestiture of certain divisions and product lines. These factors decreased cost of sales by $58 million, or 6%, $15 million, or 2%, and $13 million, respectively. Volume and changes in product mix combined to decrease cost of sales by $1 million.
Pension and other postretirement net periodic costs, including ongoing income and the interim remeasurements, increased cost of sales by $1 million compared to the prior year quarter. The current quarter remeasurement loss within cost of sales of $9 million represents the net impact of a curtailment gain of $45 million and an
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
actuarial loss of $54 million, while the prior year quarter remeasurement loss within cost of sales totaled $4 million. The remaining change relates to the ongoing pension and other postretirement income. See Note K in the Notes to Condensed Consolidated Financial Statements for further discussion on the current quarter's pension and other postretirement benefit plans activity. Additionally, as part of a restructuring plan within an existing manufacturing facility in the Specialty Ingredients reportable segment, the prior year quarter included $16 million of severance and other costs and $2 million of accelerated depreciation, while the current quarter only included $2 million of accelerated depreciation.
Year-to-Date - Cost of sales for the current period decreased $311 million compared to the prior year period primarily due to lower production costs, the net impact of the acquisition and divestiture of certain divisions and product lines, and favorable foreign currency exchange. These factors decreased cost of sales by $133 million, or 7%, $79 million, or 4%, and $54 million, or 3%, respectively. Volume and changes in product mix combined to decrease cost of sales by $22 million.
Pension and other postretirement net periodic costs, including ongoing income and the interim remeasurements, decreased cost of sales by $4 million compared to the prior year period. The current period remeasurement loss within cost of sales of $9 million represents the net impact of a curtailment gain of $45 million and an actuarial loss of $54 million, while the prior year period remeasurement loss within cost of sales totaled $4 million. The remaining change relates to the ongoing pension and other postretirement income. See Note K in the Notes to Condensed Consolidated Financial Statements for further discussion on the current quarter's pension and other postretirement benefit plans activity. Additionally, as part of a restructuring plan within an existing manufacturing facility in the Specialty Ingredients reportable segment, the current period included a $5 million reversal of the severance accrual and $4 million of accelerated depreciation, compared to the prior year period which included $16 million of severance and other costs and $2 million of accelerated depreciation.
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31 | | Six months ended March 31 |
(In millions) | 2016 |
| | 2015 |
| | Change |
| | 2016 |
| | 2015 |
| | Change |
|
Selling, general and administrative | | | | | | | | | | | |
expense | $ | 258 |
| | $ | 203 |
| | $ | 55 |
| | $ | 483 |
| | $ | 429 |
| | $ | 54 |
|
As a percent of sales | 20.7 | % | | 15.0 | % | | |
| | 20.0 | % | | 15.7 | % | | |
|
Current Quarter - Selling, general and administrative expense for the current quarter increased $55 million compared to the prior year quarter with expenses as a percent of sales increasing 5.7 percentage points. Key drivers of the fluctuation in selling, general and administrative expense compared to the prior year quarter were:
| |
• | $12 million of costs related to the separation of Valvoline and $4 million of restructuring charges related to office buildings during the current quarter; |
| |
• | Tax indemnification income of $16 million included in the prior year quarter; |
| |
• | Increased pension and other postretirement plan remeasurements losses of $9 million compared to prior year quarter. The current quarter includes $14 million of losses on pension and other postretirement plan remeasurements consisting of a curtailment gain of $65 million and an actuarial loss of $79 million, while the prior year quarter included $5 million of a loss on a pension plan remeasurement; |
| |
• | a $5 million charge for a legal reserve during the current quarter; and |
| |
• | increased resource costs of $7 million, primarily due to employee related costs. |
Year-to-Date - Selling, general and administrative expense for the current period increased $54 million compared to the prior year period with expenses as a percent of sales increasing 4.3 percentage points. Key drivers of the fluctuation in selling, general and administrative expense compared to the prior year period were:
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
| |
• | $18 million of costs related to the separation of Valvoline and $4 million of restructuring charges related to office buildings during the current period; |
| |
• | Tax indemnification income of $16 million included in the prior year period; |
| |
• | a $15 million charge for a legal reserve during the current period; |
| |
• | Increased pension and other postretirement plan remeasurements losses of $9 million compared to prior year period (see discussion within current quarter analysis); and |
| |
• | a $7 million charge related to a stock incentive award modification during the prior year period. |
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31 | | Six months ended March 31 |
(In millions) | 2016 |
| | 2015 |
| | Change |
| | 2016 |
| | 2015 |
| | Change |
|
Research and development expense | $ | 25 |
| | $ | 25 |
| | $ | — |
| | $ | 49 |
| | $ | 50 |
| | $ | (1 | ) |
Current Quarter - Research and development expense remained consistent with the prior year quarter.
Year-to-Date - Research and development expense remained consistent with the prior year period.
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31 | | Six months ended March 31 |
(In millions) | 2016 |
| | 2015 |
| | Change |
| | 2016 |
| | 2015 |
| | Change |
|
Equity and other income (loss) | |
| | |
| | |
| | |
| | |
| | |
|
Equity income (loss) | $ | 3 |
| | $ | (10 | ) | | $ | 13 |
| | $ | 8 |
| | $ | (7 | ) | | $ | 15 |
|
Other income | 3 |
| | 6 |
| | (3 | ) | | 7 |
| | 13 |
| | (6 | ) |
| $ | 6 |
| | $ | (4 | ) | | $ | 10 |
| | $ | 15 |
| | $ | 6 |
| | $ | 9 |
|
Current Quarter - The increase of $10 million in equity and other income during the current quarter is primarily due to the $14 million impairment of a Venezuelan joint venture equity investment within the Valvoline reportable segment during the prior year quarter.
Year-to-Date - As noted previously, the increase of $9 million in equity and other income in the current period is primarily due to the $14 million impairment of a Venezuelan joint venture equity investment within the Valvoline reportable segment during the prior year period.
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31 | | Six months ended March 31 |
(In millions) | 2016 |
| | 2015 |
| | Change |
| | 2016 |
| | 2015 |
| | Change |
|
Net interest and other financing | | | | | | | | | | | |
expense (income) | | | | | | | | | | | |
Interest expense | $ | 44 |
| | $ | 40 |
| | $ | 4 |
| | $ | 87 |
| | $ | 81 |
| | $ | 6 |
|
Interest income | (1 | ) | | (2 | ) | | 1 |
| | (2 | ) | | (4 | ) | | 2 |
|
Available-for-sale securities income | (2 | ) | | — |
| | (2 | ) | | (4 | ) | | — |
|
| (4 | ) |
Other financing costs | 2 |
| | 2 |
| | — |
| | 4 |
| | 4 |
| | — |
|
| $ | 43 |
| | $ | 40 |
| | $ | 3 |
| | $ | 85 |
| | $ | 81 |
| | $ | 4 |
|
Current Quarter - Net interest and other financing expense in the current quarter included available-for-sale securities income of $2 million which represents investment income related to restricted investments discussed in Note F of the Notes to Condensed Consolidated Financial Statements. Interest expense increased compared to the prior year quarter as a result of higher debt levels.
Year-to-Date - Net interest and other financing expense in the current period included available-for-sale securities income of $4 million which represents investment income related to restricted investments discussed
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
in Note F of the Notes to Condensed Consolidated Financial Statements. Interest expense increased compared to the prior year period as a result of higher debt levels.
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31 | | Six months ended March 31 |
(In millions) | 2016 |
| | 2015 |
| | Change |
| | 2016 |
| | 2015 |
| | Change |
|
Net loss on divestitures | | | | | | | | | | | |
Valvoline car care products | $ | — |
| | $ | (26 | ) | | $ | 26 |
| | $ | — |
| | $ | (26 | ) | | $ | 26 |
|
Elastomers | — |
| | (1 | ) | | 1 |
| | — |
| | (86 | ) | | 86 |
|
MAP Transaction adjustments | (1 | ) | | (6 | ) | | 5 |
| | — |
| | (6 | ) | | 6 |
|
Castings Solutions joint venture | — |
| | — |
| | — |
| | 1 |
| | — |
| | 1 |
|
Pinova | (1 | ) | | — |
| | (1 | ) | | (1 | ) | | — |
| | (1 | ) |
| $ | (2 | ) | | $ | (33 | ) | | $ | 31 |
| | $ | — |
| | $ | (118 | ) | | $ | 118 |
|
Current Quarter - The activity in the prior year quarter relates primarily to the $26 million impairment for the Valvoline car care product assets and the $7 million reduction of the MAP Transaction receivable due to the January 2015 asbestos insurance settlement.
Year-to-Date - The prior year period loss includes the pre-tax loss on sale related to Elastomers of $86 million, the $26 million impairment for the Valvoline car care product assets, and the adjustment to the MAP Transaction receivable noted above.
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31 | | Six months ended March 31 |
(In millions) | 2016 |
| | 2015 |
| | Change |
| | 2016 |
| | 2015 |
| | Change |
|
Income tax expense | $ | 15 |
| | $ | 25 |
| | $ | (10 | ) | | $ | 35 |
| | $ | 27 |
| | $ | 8 |
|
Effective tax rate | 15 | % | | 21 | % | | |
| | 16 | % | | 17 | % | | |
|
Current Quarter - The overall effective tax rate was 15% for the three months ended March 31, 2016 and was impacted by net favorable discrete items of $7 million, primarily related to a favorable tax liquidation resolution and the reversal of unrecognized tax benefits due to lapse of the statute of limitations.
The overall effective tax rate was 21% for the three months ended March 31, 2015 and was impacted by $4 million of discrete tax benefits primarily related to the release of a valuation reserve on certain deferred taxes.
Year-to-Date - The overall effective tax rate was 16% for the six months ended March 31, 2016 and was impacted by net favorable discrete items of $13 million, primarily related to the law change from the reinstatement of research and development credit, a favorable tax liquidation resolution and the reversal of unrecognized tax benefits due to lapse of the statute of limitations.
The overall effective tax rate of 17% for the six months ended March 31, 2015 included the prior quarter discrete items discussed previously.
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31 | | Six months ended March 31 |
(In millions) | 2016 |
| | 2015 |
| | Change |
| | 2016 |
| | 2015 |
| | Change |
|
Income (loss) from discontinued | | | | | | | | | | | |
operations (net of tax) | | | | | | | | | | | |
Asbestos-related litigation | $ | — |
| | $ | 122 |
| | $ | (122 | ) | | $ | — |
| | $ | 120 |
| | $ | (120 | ) |
Water Technologies | — |
| | 7 |
| | (7 | ) | | (2 | ) | | 1 |
| | (3 | ) |
| $ | — |
| | $ | 129 |
| | $ | (129 | ) | | $ | (2 | ) | | $ | 121 |
| | $ | (123 | ) |
Current Quarter - The prior year quarter included an after-tax gain of $120 million related to January 2015 asbestos insurance settlement discussed in Note K of the Notes to the Condensed Consolidated Financial Statements. The prior year quarter Ashland Water Technologies (Water Technologies) activity relates primarily
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
to post-closing adjustments as defined by the definitive agreement, including income of $5 million related to a foreign pension plan remeasurement discussed in Note K of the Notes to the Condensed Consolidated Financial Statements.
Year-to-Date - The current period included tax adjustments related to the sale of Water Technologies. The prior year period included an after-tax gain of $120 million related to the January 2015 asbestos insurance settlement.
Other comprehensive income (loss)
A comparative analysis of the components of other comprehensive income (loss) is provided below for the three and six months ended March 31, 2016 and 2015.
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31 | | Six months ended March 31 |
(In millions) | 2016 |
| | 2015 |
| | Change |
| | 2016 |
| | 2015 |
| | Change |
|
Other comprehensive income | | | | | | | | | | | |
(loss) (net of taxes) | | | | | | | | | | | |
Unrealized translation income (loss) | $ | 80 |
| | $ | (255 | ) | | $ | 335 |
| | $ | 19 |
| | $ | (382 | ) | | $ | 401 |
|
Pension and postretirement | | | | | | | | | | | |
obligation adjustment | 24 |
| | (6 | ) | | 30 |
| | 21 |
| | (11 | ) | | 32 |
|
Unrealized gain on available-for-sale | | | | | | | | | | | |
securities | 3 |
| | — |
| | 3 |
| | 9 |
| | — |
| | 9 |
|
| $ | 107 |
| | $ | (261 | ) | | $ | 368 |
| | $ | 49 |
| | $ | (393 | ) | | $ | 442 |
|
Current Quarter - Total other comprehensive income (loss), net of tax, for the current quarter increased $368 million compared to the prior year quarter as a result of the following components:
| |
• | For the three months ended March 31, 2016, other comprehensive income, net of tax, from foreign currency translation adjustments was $80 million, compared to a loss of $255 million for the three months ended March 31, 2015. The fluctuations in unrealized translation gains and losses is primarily due to translating foreign subsidiary financial statements from local currencies to U.S. Dollars. |
| |
• | Pension and postretirement obligation adjustment was income of $24 million and loss of $6 million for the three months ended March 31, 2016 and 2015, respectively. Of these amounts, $31 million and $6 million during the current quarter and prior year quarter, respectively, of unrecognized prior service credits, net of tax, relating to pension and other postretirement benefit plans were amortized and reclassified into net income. Additional unrecognized prior service credits, net of tax, of $55 million during the current quarter were included in other comprehensive income as a result of the pension and other postretirement plan remeasurements. |
| |
• | $3 million of unrealized gain on available-for-sale securities, net of tax, related to restricted investments, was recognized within other comprehensive income during the three months ended March 31, 2016. |
Year-to-Date - Total other comprehensive income (loss), net of tax, for the current period increased $442 million compared to the prior year period as a result of the following components:
| |
• | For the six months ended March 31, 2016, other comprehensive income , net of tax, from foreign currency translation adjustments was $19 million, compared to a loss of $382 million for the six months ended March 31, 2015. The fluctuations in unrealized translation gains and losses are primarily due to translating foreign subsidiary financial statements from local currencies to U.S. Dollars. |
| |
• | Pension and postretirement obligation adjustment was income of $21 million and loss of $11 million for the six months ended March 31, 2016 and 2015, respectively. Of these amounts, $34 million and $11 million during the current and prior year periods, respectively, of unrecognized prior service credits, net |
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
of tax, relating to pension and other postretirement benefit plans were amortized and reclassified into net income. Additional unrecognized prior service credits, net of tax, of $55 million during the current period were included in other comprehensive income as a result of the pension and other postretirement plan remeasurements.
| |
• | $9 million of unrealized gain on available-for-sale securities, net of tax, related to restricted investments, was recognized within other comprehensive income during the six months ended March 31, 2016. |
RESULTS OF OPERATIONS – REPORTABLE SEGMENT REVIEW
Ashland’s businesses are managed within three reportable segments: Specialty Ingredients, Performance Materials and Valvoline.
Results of Ashland’s reportable segments are presented based on its management structure and internal accounting practices. The structure and practices are specific to Ashland; therefore, the financial results of Ashland’s reportable segments are not necessarily comparable with similar information for other comparable companies. Ashland allocates all costs to its reportable segments except for certain significant company-wide restructuring activities, such as the restructuring plans described in Note E of the Notes to Condensed Consolidated Financial Statements, and other costs or adjustments that generally relate to former businesses that Ashland no longer operates. The service cost component of pension and other postretirement benefits costs is allocated to each reportable segment on a ratable basis; while the remaining components of pension and other postretirement benefits costs are recorded to Unallocated and other. Ashland refines its expense allocation methodologies to the reportable segments from time to time as internal accounting practices are improved, more refined information becomes available and businesses change. Revisions to Ashland’s methodologies that are deemed insignificant are applied on a prospective basis.
The EBITDA and Adjusted EBITDA amounts presented within this business section are provided as a means to enhance the understanding of financial measurements that Ashland has internally determined to be relevant measures of comparison for each segment. Each of these non-GAAP measures is defined as follows: EBITDA (operating income (loss) plus depreciation and amortization), Adjusted EBITDA (EBITDA adjusted for key items, which may include pro forma effects for significant acquisitions or divestitures, as applicable), and Adjusted EBITDA margin (Adjusted EBITDA, which may include pro forma adjustments, divided by sales or sales adjusted for pro forma results). Ashland does not allocate items to each reportable segment below operating income, such as interest expense and income taxes. As a result, reportable segment EBITDA and Adjusted EBITDA are reconciled directly to operating income since it is the most directly comparable Statements of Consolidated Comprehensive Income caption.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
The following table discloses sales, operating income, depreciation and amortization and statistical operating information by reportable segment for the three and six months ended March 31, 2016 and 2015. |
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31 | | March 31 |
(In millions) | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
Sales | | | | | | | |
Specialty Ingredients | $ | 529 |
| | $ | 583 |
| | $ | 1,004 |
| | $ | 1,144 |
|
Performance Materials | 239 |
| | 286 |
| | 470 |
| | 623 |
|
Valvoline | 479 |
| | 481 |
| | 936 |
| | 974 |
|
| $ | 1,247 |
| | $ | 1,350 |
| | $ | 2,410 |
| | $ | 2,741 |
|
Operating income (loss) | |
| | |
| | |
| | |
|
Specialty Ingredients | $ | 65 |
| | $ | 65 |
| | $ | 103 |
| | $ | 125 |
|
Performance Materials | 20 |
| | 30 |
| | 43 |
| | 55 |
|
Valvoline | 105 |
| | 82 |
| | 197 |
| | 165 |
|
Unallocated and other | (43 | ) | | 16 |
| | (45 | ) | | 17 |
|
| $ | 147 |
| | $ | 193 |
| | $ | 298 |
| | $ | 362 |
|
Depreciation and amortization | |
| | |
| | |
| | |
|
Specialty Ingredients | $ | 62 |
| | $ | 61 |
| | $ | 123 |
| | $ | 121 |
|
Performance Materials | 13 |
| | 14 |
| | 26 |
| | 30 |
|
Valvoline | 10 |
| | 10 |
| | 19 |
| | 19 |
|
| $ | 85 |
| | $ | 85 |
| | $ | 168 |
| | $ | 170 |
|
Operating information | |
| | |
| | |
| | |
|
Specialty Ingredients | |
| | |
| | |
| | |
|
Sales per shipping day | $ | 8.3 |
| | $ | 9.3 |
| | $ | 8.0 |
| | $ | 9.2 |
|
Metric tons sold (thousands) | 77.3 |
| | 82.7 |
| | 146.0 |
| | 162.6 |
|
Gross profit as a percent of sales (a) | 34.6 | % | | 31.7 | % | | 33.8 | % | | 32.2 | % |
Performance Materials | |
| | | | |
| | |
Sales per shipping day | $ | 3.7 |
| | $ | 4.5 |
| | $ | 3.7 |
| | $ | 5.0 |
|
Metric tons sold (thousands) | 116.3 |
| | 118.3 |
| | 222.5 |
| | 247.8 |
|
Gross profit as a percent of sales (a) | 20.6 | % | | 22.7 | % | | 21.3 | % | | 19.8 | % |
Valvoline | |
| | |
| | |
| | |
|
Lubricant sales gallons | 43.7 |
| | 40.5 |
| | 84.2 |
| | 79.5 |
|
Premium lubricants (percent of U.S. branded volumes) | 44.6 | % | | 40.7 | % | | 43.9 | % | | 39.6 | % |
Gross profit as a percent of sales (a) | 40.0 | % | | 36.1 | % | | 39.2 | % | | 34.7 | % |
| | | | | | | |
| |
(a) | Gross profit is defined as sales, less cost of sales divided by sales. |
Sales by region expressed as a percentage of reportable segment sales for the three and six months ended March 31, 2016 and 2015 were as follows. Ashland includes only U.S. and Canada in its North American designation.
|
| | | | | | | | | | | | | | | | | |
| Three months ended March 31, 2016 | | Six months ended March 31, 2016 |
Sales by Geography | Specialty Ingredients | | Performance Materials | | Valvoline | | Specialty Ingredients | | Performance Materials | | Valvoline |
North America | 39 | % | | 42 | % | | 75 | % | | 39 | % | | 41 | % | | 75 | % |
Europe | 31 | % | | 40 | % | | 7 | % | | 32 | % | | 39 | % | | 7 | % |
Asia Pacific | 19 | % | | 13 | % | | 13 | % | | 19 | % | | 14 | % | | 13 | % |
Latin America & other | 11 | % | | 5 | % | | 5 | % | | 10 | % | | 6 | % | | 5 | % |
| 100 | % | | 100 | % | | 100 | % | | 100 | % | | 100 | % | | 100 | % |
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
|
| | | | | | | | | | | | | | | | | |
| Three months ended March 31, 2015 | | Six months ended March 31, 2015 |
Sales by Geography | Specialty Ingredients | | Performance Materials | | Valvoline | | Specialty Ingredients | | Performance Materials | | Valvoline |
North America | 39 | % | | 42 | % | | 75 | % | | 39 | % | | 45 | % | | 75 | % |
Europe | 32 | % | | 39 | % | | 7 | % | | 32 | % | | 35 | % | | 7 | % |
Asia Pacific | 19 | % | | 14 | % | | 13 | % | | 19 | % | | 14 | % | | 14 | % |
Latin America & other | 10 | % | | 5 | % | | 5 | % | | 10 | % | | 6 | % | | 4 | % |
| 100 | % | | 100 | % | | 100 | % | | 100 | % | | 100 | % | | 100 | % |
Specialty Ingredients
Specialty Ingredients is a global leader in cellulose ethers, vinyl pyrrolidones and biofunctionals. It offers industry-leading products, technologies and resources for solving formulation and product-performance challenges. Specialty Ingredients uses natural, synthetic and semisynthetic polymers derived from plant and seed extract, cellulose ethers, vinyl pyrrolidones, acrylic polymers as well as polyester and polyurethane-based adhesives. Specialty Ingredients includes two divisions, Consumer Specialties and Industrial Specialties, that offer comprehensive and innovative solutions for today’s demanding consumer and industrial applications. Key customers include: pharmaceutical companies; makers of personal care products, food and beverages; manufacturers of paint, coatings and construction materials; packaging and converting; and oilfield service companies.
March 2016 quarter compared to March 2015 quarter
Specialty Ingredients’ sales decreased $54 million to $529 million in the current quarter. Energy market sales decreased $16 million compared to prior year quarter primarily due to lower volume as a result of reduced demand by customers, specifically those within industries negatively impacted by oil prices. Excluding the effect of the energy market, sales decreased by $38 million, with pricing declines decreasing sales by $13 million. Changes in volume and product mix combined to decrease sales by $9 million, while unfavorable foreign currency exchange decreased sales by $6 million due to the U.S. dollar strengthening compared to various foreign currencies, primarily the Euro. The divestiture of the industrial biocides assets and the exit from the redispersible powders product line decreased sales by $8 million and $2 million, respectively.
Gross profit during the current quarter decreased $2 million compared to the prior year quarter. As part of a restructuring plan within an existing manufacturing facility, the prior year quarter included expense of $16 million related to severance and other costs, while both the current and prior year quarter included accelerated depreciation of $2 million. Gross profit within the energy market decreased $5 million compared to the prior year quarter primarily driven by lower volume. Excluding the energy market and the costs noted previously, gross profit decreased by $13 million compared to the prior year quarter, with volume and changes in product mix combining to decrease gross profit by $8 million. Unfavorable currency exchange and the divested and exited product lines each decreased gross profit by $2 million during the current period. Pricing declines were offset by lower raw material costs, while manufacturing cost increased slightly, resulting in a $1 million decrease in gross profit. In total, gross profit margin during the current quarter increased 2.9 percentage points as compared to the prior year quarter to 34.6%, primarily due to favorable product mix and cost improvements.
Selling, general and administrative expenses (which include research and development expenses throughout the reportable segment discussion and analysis) decreased $2 million in the current quarter as compared to the prior year quarter primarily due to $2 million of favorable foreign currency exchange. Inflationary increases were offset by cost savings initiatives. Equity and other income (loss) remained consistent with the prior year quarter.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
Operating income totaled $65 million in both the current and prior year quarter. EBITDA increased $1 million to $125 million in the current quarter, while Adjusted EBITDA decreased $15 million to $127 million in the current quarter. Adjusted EBITDA margin decreased 0.4 percentage points in the current quarter to 24.0%.
Fiscal 2016 year-to-date compared to fiscal 2015 year-to-date
Specialty Ingredients' sales decreased $140 million to $1,004 million in the current period. Energy market sales decreased $45 million compared to prior year period primarily due to lower volume as a result of reduced demand by customers, specifically those within industries negatively impacted by oil prices. Excluding the effect of the energy market, sales decreased by $95 million, with unfavorable foreign currency exchange decreasing sales by $25 million due to the U.S. dollar strengthening compared to various foreign currencies, primarily the Euro. Pricing declines decreased sales by $24 million, while changes in volume and product mix combined to decrease sales by $21 million. The divestiture of the industrial biocides assets and the exit from the redispersible powders product line decreased sales by $15 million and $10 million, respectively.
Gross profit during the current period decreased $30 million compared to the prior year period. As part of a restructuring plan within an existing manufacturing facility, the prior year period included expense of $16 million and accelerated depreciation of $2 million, while the current period included $5 million of income related to reversal of a previous severance accrual and $4 million of accelerated depreciation. Gross profit within the energy market decreased $14 million compared to the prior year period primarily as a result of the unfavorable impact of lower volumes.
Excluding the energy market and costs noted previously, gross profit decreased $35 million compared to the prior year period. Volume and changes in product mix combined to decrease gross profit by $13 million and unfavorable foreign currency exchange decreased gross profit by $12 million. Planned plant maintenance turnarounds reduced gross profit by $13 million during the current period, while the net of lower raw material costs and higher production costs more than offset pricing declines to increase gross profit by $6 million. The divestiture of the industrial biocides assets decreased gross profit by $3 million during the current period. In total, gross profit margin during the current period increased 1.6 percentage points to 33.8% compared to the prior year period, primarily due to favorable mix and cost.
Selling, general and administrative expenses decreased $8 million in the current period as compared to the prior year period. The decrease was primarily due to favorable foreign currency exchange of $7 million. Inflationary increases and increased allocated resource costs were offset by other savings initiatives. Equity and other income (loss) remained consistent with the prior year period.
Operating income totaled $103 million for the current period compared to $125 million in the prior year period. EBITDA decreased $22 million to $222 million in the current period, while Adjusted EBITDA decreased $41 million to $221 million in the current period. Adjusted EBITDA margin decreased 0.9 percentage points in the current period to 22.0%.
EBITDA and Adjusted EBITDA reconciliation
The following EBITDA presentation for the three and six months ended March 31, 2016 and 2015 below is provided as a means to enhance the understanding of financial measurements that Ashland has internally determined to be relevant measures of comparison for the results of Specialty Ingredients. Adjusted EBITDA results have been prepared to illustrate the ongoing effects of Ashland's operations, which exclude certain key items. The key items within both quarters and periods relate specifically to the manufacturing facility restructuring plan. The current quarter includes $2 million of accelerated depreciation; while the prior year quarter and period includes $16 million of severance and other costs and $2 million of accelerated depreciation. The current period reflects a $5 million income adjustment for severance and $4 million of accelerated depreciation.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31 | | March 31 |
(In millions) | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
Operating income | $ | 65 |
| | $ | 65 |
| | $ | 103 |
| | $ | 125 |
|
Depreciation and amortization (a) | 60 |
| | 59 |
| | 119 |
| | 119 |
|
EBITDA | 125 |
| | 124 |
| | 222 |
| | 244 |
|
Severance and other costs | — |
| | 16 |
| | (5 | ) | | 16 |
|
Accelerated depreciation | 2 |
| | 2 |
| | 4 |
| | 2 |
|
Adjusted EBITDA | $ | 127 |
| | $ | 142 |
| | $ | 221 |
| | $ | 262 |
|
| | | | | | | |
| |
(a) | Excludes $2 million of accelerated depreciation for the three months ended March 31, 2016 and 2015, while the six months ended March 31, 2016 and 2015 excludes accelerated depreciation of $4 million and $2 million, respectively. |
Performance Materials
Performance Materials is a global leader in unsaturated polyester resins and vinyl ester resins. The business unit has leading positions in gelcoats, maleic anhydride, butanediol, tetrahydrofuran, N-Methylpyrrolidone and other intermediates and solvents. Key customers include: manufacturers of residential and commercial building products; industrial product specifiers and manufacturers; wind blade and pipe manufacturers; automotive and truck OEM suppliers; boatbuilders; engineered plastics and electronic producers; and specialty chemical manufacturers.
Subsequent to the sale of Elastomers on December 1, 2014, Performance Materials is comprised of two divisions: Composites and Intermediates/Solvents. Elastomers results were included in the Performance Materials reportable segment results of operations within the Statements of Consolidated Comprehensive Income until its December 1, 2014 sale.
For additional information on the divestiture of the Elastomers division, see Note C of the Notes to Condensed Consolidated Financial Statements.
March 2016 quarter compared to March 2015 quarter
Performance Materials’ sales decreased $47 million to $239 million in the current quarter. Lower product pricing and unfavorable foreign currency exchange decreased sales by $29 million, or 10%, and $7 million, or 2%, respectively. Unfavorable foreign currency exchange was due to the U.S. dollar strengthening compared to various foreign currencies, primarily the Euro, during the current quarter. Changes in product mix and volume decreased sales by $6 million and $5 million, respectively.
Gross profit decreased $16 million in the current quarter compared to the prior year quarter primarily driven by pricing declines that decreased gross profit by $15 million. This decline in pricing included the offset of lower raw material costs within the Composites division. The impact on gross profit of unfavorable foreign currency and changes in volume and product mix combined to essentially offset during the current quarter. In total, gross profit margin decreased 2.1 percentage points as compared to the prior year quarter to 20.6%.
Selling, general and administrative expenses decreased $4 million during the current quarter compared to the prior year quarter, primarily due to a decline in incentive compensation expense of $3 million and a favorable foreign currency exchange of $1 million. Equity and other income increased $2 million compared to the prior year quarter primarily due to an increase in other income.
Operating income totaled $20 million in the current quarter compared to $30 million in the prior year quarter. EBITDA decreased $11 million to $33 million in the current quarter, while EBITDA margin decreased 1.6 percentage points in the current quarter to 13.8%. There were no unusual or key items that affected comparability for EBITDA during the current and prior year quarters.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
Fiscal 2016 year-to-date compared to fiscal 2015 year-to-date
Performance Materials' sales decreased $153 million in the current period to $470 million. Lower product pricing decreased sales by $61 million, or 10%. The divestiture of the Elastomers division resulted in a loss of sales of $40 million, or 6%, and unfavorable foreign currency exchange decreased sales by $25 million, or 4%. Changes in product mix and lower volume decreased sales by $14 million and $13 million, respectively.
Gross profit decreased $22 million in the current period compared to the prior year period. The unfavorable impact of pricing declines, partially offset by lower product costs, decreased gross profit by $11 million. Changes in product mix and volume combined to decrease gross profit by $5 million. The sale of Elastomers and unfavorable foreign currency exchange each decreased gross profit by $3 million. In total, gross profit margin increased 1.5 percentage points to 21.3%, as compared to the prior year period due to favorable mix, primarily from the Elastomers sale.
Selling, general and administrative expenses decreased $10 million during the current period compared to the prior year period, primarily due to decreased incentive compensation of $5 million, the sale of the Elastomers division of $3 million and a favorable foreign currency exchange of $2 million. Equity and other income remained consistent with the prior year period.
Operating income totaled income of $43 million in the current period compared to $55 million in the prior year period. EBITDA decreased $16 million to $69 million in the current period. EBITDA margin increased 1.1 percentage points in the current period to 14.7%. There were no unusual or key items that affected comparability for EBITDA in the current and prior year periods.
EBITDA and Adjusted EBITDA reconciliation
The following EBITDA presentation for the three and six months ended March 31, 2016 and 2015 below is provided as a means to enhance the understanding of financial measurements that Ashland has internally determined to be relevant measures of comparison for the results of Performance Materials. There were no unusual or key items that affected comparability for EBITDA during the current and prior year quarters or periods.
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31 | | March 31 |
(In millions) | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
Operating income | $ | 20 |
| | $ | 30 |
| | $ | 43 |
| | $ | 55 |
|
Depreciation and amortization | 13 |
| | 14 |
| | 26 |
| | 30 |
|
EBITDA | $ | 33 |
| | $ | 44 |
| | 69 |
| | 85 |
|
Valvoline
Valvoline is a leading, worldwide producer and distributor of premium-branded automotive, commercial and industrial lubricants and automotive chemicals. It ranks as the #2 quick-lube chain and #3 passenger car motor oil brand in the United States. The brand operates and franchises 1,052 Valvoline Instant Oil ChangeSM centers in the United States. It also markets Valvoline™ lubricants and automotive chemicals; MaxLife™ lubricants created for higher-mileage engines; SynPower™ synthetic motor oil; and Zerex™ antifreeze. Key customers include: retail auto parts stores and mass merchandisers who sell to consumers; installers, such as car dealers, repair shops and quick lubes; commercial fleets; and distributors.
During 2015, Ashland announced a plan to separate Valvoline into an independent, publicly traded company. The separation is expected to be completed as soon as practicable, but not before the end of fiscal 2016.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
During February 2016, Ashland completed the acquisition of Oil Can Henry's resulting in the addition of 89 quick-lube stores. For additional information on the separation and acquisition, see the “Key Developments” section of Management’s Discussion and Analysis herein.
During the June 2015 quarter, Ashland sold its Valvoline car care product assets, which included Car Brite™ and Eagle One™ automotive appearance products, and sold its joint venture equity investment within Venezuela. See Note C of the Notes to Condensed Consolidated Financial Statements for further information.
March 2016 quarter compared to March 2015 quarter
Valvoline’s sales decreased $2 million to $479 million in the current quarter. Higher volume increased sales by $31 million, or 7%, as lubricant gallons sold increased to 43.7 million, while lower product pricing decreased sales by $27 million, or 6%. Unfavorable foreign currency exchange, due to the U.S. dollar strengthening compared to various foreign currencies, primarily the Euro and Australian dollar, decreased sales by $9 million, while changes in product mix increased sales by $9 million. The divestiture of Valvoline car care product assets which decreased sales by $13 million was partially offset by increased sales from the acquisition of Oil Can Henry's of $7 million.
Gross profit increased $18 million during the current quarter compared to the prior year quarter. Changes in volume and product mix combined to increase gross profit by $16 million, while lower raw material costs, increased gross profit by $5 million. The lower raw material costs were partially offset by lower product pricing. Unfavorable foreign currency exchange and the divestiture of Valvoline car care product assets, partially offset by favorable gross profit relating to Oil Can Henry's, decreased gross profit by $2 million and $1 million, respectively. In total, gross profit margin increased 3.9 percentage points as compared to the prior year quarter to 40.0%.
Selling, general and administrative expenses increased $8 million during the current quarter as compared to the prior year quarter, primarily due to employee cost increases of $3 million, increased advertising costs and consulting costs of $2 million each, and increased allocated resources costs of $1 million. The savings from the car care product assets divestiture were essentially offset by the additional operating expenses related to the acquisition of Oil Can Henry's. Equity and other income increased $13 million compared to the prior year quarter primarily due to the $14 million impairment of the Venezuelan joint venture equity investment in the prior year quarter.
Operating income totaled $105 million in the current quarter as compared to $82 million in the prior year quarter. EBITDA increased $23 million to $115 million in the current quarter, while Adjusted EBITDA increased $9 million. Adjusted EBITDA margin increased 2.0 percentage points to 24.0% in the current quarter.
Fiscal 2016 year-to-date compared to fiscal 2015 year-to-date
Valvoline's sales decreased $38 million in the current period to $936 million. Lower product pricing decreased sales by $53 million, or 5%, while higher volume levels increased sales by $46 million, or 5%, as lubricant gallons sold increased to 84.2 million. Unfavorable foreign currency exchange decreased sales by $26 million, or 3%, while changes in product mix increased sales by $16 million, or 2%. Unfavorable foreign currency exchange was primarily due to the U.S. dollar strengthening compared to various foreign currencies, primarily the Euro and Australian dollar. The divestiture of Valvoline car care product assets decreased sales by $28 million, or 3%, while the acquisition of Oil Can Henry's increased sales by $7 million.
Gross profit increased $29 million during the current period compared to the prior year period. Changes in volume and product mix combined to increase gross profit by $25 million, and lower raw material costs increased gross profit by $13 million. Lower raw material costs were partially offset by lower product pricing. Unfavorable foreign currency exchange and the divestiture of Valvoline car care product assets, partially offset by favorable gross profit relating to the Oil Can Henry's acquisition, decreased gross profit by $7 million and $2 million, respectively. In total, gross profit margin increased 4.5 percentage points to 39.2%.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
Selling, general and administrative expense increased $10 million during the current period as compared to the prior year period, primarily driven by increased advertising costs of $5 million, increased consulting costs and allocated resources costs of $3 million each, and $2 million of increased employee costs. These increases were partially offset by favorable foreign currency exchange and the net favorable impact of the divestiture of car care products assets and the acquisition of Oil Can Henry's. Equity and other income (loss) increased $13 million primarily due to the $14 million impairment of the Venezuelan joint venture equity investment in the prior period.
Operating income totaled $197 million in the current period as compared to $165 million in the prior year period. EBITDA increased $32 million to $216 million in the current period, while Adjusted EBITDA increased $18 million. Adjusted EBITDA margin increased 2.8 percentage points to 23.1% in the current period.
EBITDA and Adjusted EBITDA reconciliation
The following EBITDA presentation for the three and six months ended March 31, 2016 and 2015 is provided as a means to enhance the understanding of financial measurements that Ashland has internally determined to be relevant measures of comparison for the results of Valvoline. Adjusted EBITDA results have been prepared to illustrate the ongoing effects of Ashland's operations, which exclude certain key items. The $14 million adjustment in the prior year quarter and period relates to the impairment of a joint venture equity investment within Venezuela. There were no unusual or key items that affected comparability for EBITDA during the current quarter or period.
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31 | | March 31 |
(In millions) | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
Operating income | $ | 105 |
| | $ | 82 |
| | $ | 197 |
| | $ | 165 |
|
Depreciation and amortization | 10 |
| | 10 |
| | 19 |
| | 19 |
|
EBITDA | 115 |
| | 92 |
| | 216 |
| | 184 |
|
Impairment of equity investment | — |
| | 14 |
| | — |
| | 14 |
|
Adjusted EBITDA | $ | 115 |
| | $ | 106 |
| | $ | 216 |
| | $ | 198 |
|
Unallocated and other
The following table summarizes the key components of the Unallocated and other segment's operating income (loss) for the three and six months ended March 31, 2016 and 2015.
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31 | | March 31 |
(In millions) | 2016 |
| | 2015 |
| | 2016 |
| | 2015 |
|
Losses on pension and other postretirement plan | | | | | | | |
remeasurements | $ | (23 | ) | | $ | (9 | ) | | $ | (23 | ) | | $ | (9 | ) |
Pension and other postretirement net periodic income | | | | | | | |
(excluding service cost) | 20 |
| | 14 |
| | 40 |
| | 27 |
|
Restructuring activities (includes severance | | | | | | | |
and separation costs) | (16 | ) | | — |
| | (22 | ) | | (1 | ) |
Legal reserve | (5 | ) | | — |
| | (15 | ) | | — |
|
Tax indemnity income | — |
| | 16 |
| | — |
| | 16 |
|
Environmental expense for divested businesses | (11 | ) | | (9 | ) | | (16 | ) | | (15 | ) |
Other income (expense) | (8 | ) | | 4 |
| | (9 | ) | | (1 | ) |
Total unallocated income (expense) | $ | (43 | ) | | $ | 16 |
| | $ | (45 | ) | | $ | 17 |
|
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
March 2016 quarter compared to March 2015 quarter
Unallocated and other recorded expense of $43 million and income of $16 million for the three months ended March 31, 2016 and 2015, respectively. Unallocated and other includes pension and other postretirement net periodic costs and income that have not been allocated to reportable segments. These include interest cost, expected return on assets and amortization of prior service credit as these items are considered financing activities managed at the corporate level, as opposed to service costs which are allocated to reportable segments. The recurring pension and other postretirement components in Unallocated and other resulted in income during the current and prior year quarter of $20 million and $14 million, respectively. The change in pension and other postretirement income in the current quarter is primarily driven by the discount rate discussed further below. The current and prior year quarter also included losses of $23 million and $9 million, respectively, for key items related to pension and other postretirement plan remeasurements as discussed in the “Key Developments” section of Management’s Discussion and Analysis herein. The current quarter pension and other postretirement plan remeasurement losses represent the net impact of a curtailment gain of $110 million due to the current quarter plan amendments and an actuarial loss of $133 million resulting from the change in discount rates and asset values.
The remaining unallocated items for the current quarter primarily included $12 million of costs incurred related to the Valvoline separation, $11 million for environmental reserve adjustments, $5 million for a legal reserve, and $4 million of restructuring charges related to office buildings. In the prior year quarter, unallocated costs also included expense of $9 million for environmental reserve adjustments and $16 million of tax indemnity income.
Fiscal 2016 year-to-date compared to fiscal 2015 year-to-date
Unallocated and other recorded expense of $45 million and income of $17 million for the six months ended March 31, 2016 and 2015, respectively. Recurring pension and other postretirement plans resulted in income, within continuing operations, during the current and prior year period of $40 million and $27 million, respectively. Fluctuations in these amounts from period to period result primarily from changes in the discount rate. As discussed above within the quarterly analysis, the current and prior year periods also included remeasurement losses of $23 million and $9 million, respectively.
The remaining unallocated items during the current period primarily included expense of $18 million of costs incurred related to the Valvoline separation, $16 million for environmental reserve adjustments, $15 million for a legal reserve, and $4 million of restructuring charges related to office buildings. The remaining unallocated items for the prior year period included $16 million of tax indemnity income, expense of $15 million for environmental reserve adjustments, expense of $7 million for the stock incentive plan award modification, $4 million of certain indirect corporate costs previously allocated to Elastomers, and global restructuring expense of $1 million.
Change in Applying Discount Rate to Measure Benefit Costs
During the three months ended December 31, 2015, Ashland changed the method used to estimate the service and interest cost components of net periodic benefit cost for pension and other postretirement benefits. This change compared to the previous method resulted in a decrease in the service and interest cost components for pension and other postretirement benefit costs during the quarter. Historically, Ashland estimated these service and interest cost components utilizing a single weighted-average discount rate derived from the yield curve used to measure the benefit obligation at the beginning of the period. Ashland has elected to utilize a full yield curve approach in the estimation of these components by applying the specific spot rates along the yield curve used in the determination of the benefit obligation to the relevant projected cash flows. Ashland has made this change to provide a more precise measurement of service and interest costs by improving the correlation between projected benefit cash flows to the corresponding spot yield curve rates. This change does not affect the measurement of Ashland's total benefit obligations or annual net periodic benefit costs as the
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
change in the service and interest costs will be offset in the actuarial gain or loss reported, which typically occurs during the fourth fiscal quarter. Ashland has accounted for this change as a change in accounting estimate that is inseparable from a change in accounting principle and accordingly has accounted for it prospectively.
The impact of this discount rate change compared to the previous method will decrease estimated pension and other postretirement benefits service and interest cost by approximately $33 million for the full year 2016. The decrease during the three and six months ended March 31, 2016 was approximately $8 million and $16 million, respectively, with substantially all of the decrease attributable to interest cost. The impact on service cost is not significant due to the nature of Ashland’s largest U.S. pension plan, which is closed to new entrants and has curtailed other benefits. Of this expected annual decrease and based on plan demographics, approximately $13 million will be reported in cost of sales and approximately $20 million will be reported in selling, general, and administrative expense on a full year basis, or approximately $3 million and $5 million on a quarterly basis, respectively, within the Statements of Consolidated Comprehensive Income in the Unallocated and other segment. Service and interest cost, as well as the other components of net periodic benefit costs, are subject to change for such reasons as an event requiring a remeasurement. Ashland's total projected benefit obligations will not be impacted by these reductions in service and interest costs as the decrease will be substantially offset within the actuarial gain or loss caption when the plans are remeasured during the fiscal year.
FINANCIAL POSITION
Liquidity
Ashland had $1,136 million in cash and cash equivalents as of March 31, 2016, of which $1,117 million was held by foreign subsidiaries and had no significant limitations that would prohibit remitting the funds to satisfy corporate obligations. However, if such amounts were repatriated to the United States, additional taxes would likely need to be accrued and paid depending on the source of the earnings remitted. Ashland currently has no plans to repatriate any amounts for which additional U.S. taxes would need to be accrued.
Ashland’s cash flows from operating, investing and financing activities, as reflected in the Statements of Condensed Consolidated Cash Flows, are summarized as follows for the six months ended March 31, 2016 and 2015.
|
| | | | | | | |
| Six months ended |
| March 31 |
(In millions) | 2016 |
| | 2015 |
|
Cash provided (used) by: | | | |
Operating activities from continuing operations | $ | 250 |
| | $ | 96 |
|
Investing activities from continuing operations | (124 | ) | | (299 | ) |
Financing activities from continuing operations | (217 | ) | | (532 | ) |
Discontinued operations | (19 | ) | | 287 |
|
Effect of currency exchange rate changes on cash and cash equivalents | (11 | ) | | (34 | ) |
Net decrease in cash and cash equivalents | $ | (121 | ) | | $ | (482 | ) |
Operating activities
The following discloses the cash flows associated with Ashland’s operating activities for the six months ended March 31, 2016 and 2015.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
|
| | | | | | | |
| Six months ended |
| March 31 |
(In millions) | 2016 |
| | 2015 |
|
Cash flows provided (used) by operating activities from continuing operations | | | |
Net income | $ | 176 |
| | $ | 257 |
|
Loss (income) from discontinued operations (net of tax) | 2 |
| | (121 | ) |
Adjustments to reconcile income from continuing operations to | |
| | |
|
cash flows from operating activities | |
| | |
|
Depreciation and amortization | 168 |
| | 170 |
|
Debt issuance cost amortization | 6 |
| | 7 |
|
Deferred income taxes | 1 |
| | (13 | ) |
Equity income from affiliates | (8 | ) | | (7 | ) |
Distributions from equity affiliates | 9 |
| | 10 |
|
Stock based compensation expense | 17 |
| | 15 |
|
Gain on available-for-sale securities | (4 | ) | | — |
|
Net loss on divestitures | — |
| | 118 |
|
Impairment of equity investment | — |
| | 14 |
|
Pension contributions | (15 | ) | | (29 | ) |
Losses on pension and other postretirement plan remeasurements | 23 |
| | 9 |
|
Change in operating assets and liabilities (a) | (125 | ) | | (334 | ) |
Total cash flows provided by operating activities from continuing operations | $ | 250 |
| | $ | 96 |
|
| | | |
(a)Excludes changes resulting from operations acquired or sold.
Cash flows generated from operating activities from continuing operations, a major source of Ashland’s liquidity, amounted to cash inflows of $250 million in the current period and $96 million in the prior year period. The cash results during each period are primarily driven by net income, excluding discontinued operation results, adjusted for certain non-cash items including depreciation and amortization (including debt issuance cost amortization), losses and gains on divestitures as well as changes in working capital, which are fluctuations within accounts receivable, inventory, trade payables and accrued expenses. Ashland continues to emphasize working capital management as a high priority and focus.
Changes in net working capital accounted for outflows of $98 million for the six months ended March 31, 2016 and 2015, respectively, and were driven by the following:
| |
• | Accounts receivable - The cash inflows of $27 million and $153 million during the current and prior year periods, respectively, were primarily due to decreased sales compared to the prior year period. |
| |
• | Inventory - The cash outflow of $9 million and inflow $32 million during the current and prior year periods, respectively, were primarily a result of sales volumes. |
| |
• | Trade and other payables - The cash outflows of $116 million and $283 million during the current and prior year periods, respectively, were primarily driven by seasonal declines in trade payables and incentive compensation payouts to employees from the prior year paid during the first quarter of each fiscal year. The prior year period outflow was also due to severance payments relating to the 2014 global restructuring program. |
The remaining outflows of $27 million and $236 million in the current and prior year periods, respectively, relate primarily to adjustments to certain accruals and long term assets and liabilities and income taxes received and paid.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
Operating cash flows for the current period included income from continuing operations of $178 million and noncash adjustments of $168 million for depreciation and amortization, $23 million related to the losses on the pension and other postretirement plan remeasurements, and $6 million for debt issuance cost amortization.
Operating cash flows for the prior year period included income from continuing operations of $136 million and noncash adjustments of $170 million for depreciation and amortization, $112 million for the losses on the divestitures of the Elastomers division and on the Valvoline car care product assets, $6 million related to the MAP Transaction receivable decrease, $9 million related to the loss on the pension plan remeasurement, a $14 million impairment related to the Valvoline joint venture equity investment within Venezuela, and $7 million for debt issuance cost amortization.
Investing activities
The following discloses the cash flows associated with Ashland’s investing activities for the six months ended March 31, 2016 and 2015.
|
| | | | | | | |
| Six months ended |
| March 31 |
(In millions) | 2016 |
| | 2015 |
|
Cash flows provided (used) by investing activities from continuing operations | | | |
Additions to property, plant and equipment | $ | (103 | ) | | $ | (86 | ) |
Proceeds from disposal of property, plant and equipment | 3 |
| | 1 |
|
Purchase of operations - net of cash acquired | (66 | ) | | — |
|
Proceeds from sale of operations or equity investments | 12 |
| | 106 |
|
Funds restricted for specific transactions | — |
| | (320 | ) |
Reimbursements from restricted investments | 23 |
| | — |
|
Proceeds from the settlement of derivative instruments | 7 |
| | — |
|
Purchase of available-for-sale securities | (4 | ) | | — |
|
Proceeds from sales of available-for-sale securities | 4 |
| | — |
|
Total cash flows used by investing activities from continuing operations | $ | (124 | ) | | $ | (299 | ) |
Cash used by investing activities was $124 million and $299 million for the current and prior year periods, respectively. The significant cash investing activities for the current and prior year periods primarily related to cash outflows from property additions of $103 million and $86 million, respectively. The current period includes a net cash outlay of $66 million for the purchase of operations. This outflow primarily consisted of $60 million related to the acquisition of Oil Can Henry's. The current period also includes reimbursements of $23 million from the restrictive renewable annual trust established as a result of the January 2015 asbestos insurance settlement and proceeds from the settlement of derivative instruments of $7 million.
The prior year period included proceeds, net of estimated working capital adjustments and transactions costs, of $106 million from the sale of the Elastomers division. Funds restricted for specific transactions in the prior year period represent the restriction of the January 2015 asbestos insurance settlement funds into the trust of $335 million, partially offset by the reclassification into cash and cash equivalents of $15 million of assets previously restricted in use for property transactions.
Financing activities
The following discloses the cash flows associated with Ashland’s financing activities for the six months ended March 31, 2016 and 2015.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
|
| | | | | | | |
| Six months ended |
| March 31 |
(In millions) | 2016 |
| | 2015 |
|
Cash flows provided (used) by financing activities from continuing operations | | | |
Repayment of long-term debt | $ | (36 | ) | | $ | — |
|
Proceeds (repayment) from short-term debt | 368 |
| | (96 | ) |
Repurchase of common stock | (500 | ) | | (397 | ) |
Cash dividends paid | (48 | ) | | (46 | ) |
Excess tax benefits related to share-based payments | (1 | ) | | 7 |
|
Total cash flows used by financing activities from continuing operations | $ | (217 | ) | | $ | (532 | ) |
Cash used by financing activities was $217 million for the current period as compared to $532 million for the prior year period. Significant cash financing activities for the current period included a cash outflow of $500 million for the repurchase of common stock and cash inflows of $368 million primarily related to the debt outstanding under the 2015 revolving credit facility and the accounts receivable securitization facility. Additionally, the current period included cash dividends paid of $0.78 per share, for a total of $48 million, and the repayment of long-term debt of $36 million, primarily related to the term loan and the repayment of acquired debt from Oil Can Henry's.
Significant cash financing activities for the prior year period included $397 million for the repurchase of common stock, cash dividends paid of $0.68 per share, for a total of $46 million and repayment of short-term debt of $96 million, partially offset by $7 million for excess tax benefits related to share-based payments.
Cash provided (used) by discontinued operations
The following discloses the cash flows associated with Ashland’s discontinued operations for the six months ended March 31, 2016 and 2015.
|
| | | | | | | |
| Six months ended |
| March 31 |
(In millions) | 2016 |
| | 2015 |
|
Cash provided (used) by discontinued operations | | | |
Operating cash flows | $ | (19 | ) | | $ | 277 |
|
Investing cash flows | — |
| | 10 |
|
Total cash provided (used) by discontinued operations | $ | (19 | ) | | $ | 287 |
|
Cash flows for discontinued operations for the current period relate to other previously divested businesses, including net payments of asbestos and environmental liabilities. The current period includes the $4 million of cash receipts related to the asbestos settlements with certain insurers during the current period.
Cash flows for discontinued operations for the prior year period is primarily driven by $398 million of cash received, before taxes, related to the January 2015 asbestos insurance settlement, and $30 million of delayed cash proceeds for a foreign entity from the sale of Water Technologies. These inflows were partially offset by $90 million in tax payments and a $20 million payment for the working capital settlement related to the disposition of Water Technologies.
Free cash flow and other liquidity resources
The following represents Ashland’s calculation of free cash flow for the disclosed periods. Free cash flow does not reflect adjustments for certain non-discretionary cash flows such as mandatory debt repayments.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
|
| | | | | | | |
| Six months ended |
| March 31 |
(In millions) | 2016 |
| | 2015 |
|
Cash flows provided by operating activities from continuing operations | $ | 250 |
| | $ | 96 |
|
Adjustments: | |
| | |
|
Additions to property, plant and equipment | (103 | ) | | (86 | ) |
Free cash flows | $ | 147 |
| | $ | 10 |
|
Free cash flows for fiscal year 2016 are estimated at approximately $325 million to $350 million. At March 31, 2016, working capital (current assets minus current liabilities, excluding long-term debt due within one year) amounted to $1,265 million as of March 31, 2016, compared to $1,706 million at September 30, 2015. Ashland’s working capital is affected by its use of the LIFO method of inventory valuation that valued inventories below their replacement costs by $27 million at March 31, 2016 and $34 million at September 30, 2015. Liquid assets (cash, cash equivalents and accounts receivable) amounted to 122% and 154% of current liabilities at March 31, 2016 and September 30, 2015, respectively.
The following summary reflects Ashland’s cash and unused borrowing capacity as of March 31, 2016 and September 30, 2015.
|
| | | | | | | |
| March 31 |
| | September 30 |
|
(In millions) | 2016 |
| | 2015 |
|
Cash and cash equivalents | $ | 1,136 |
| | $ | 1,257 |
|
| | | |
Unused borrowing capacity | |
| | |
|
Revolving credit facility | $ | 575 |
| | $ | 1,013 |
|
Accounts receivable securitization facility | $ | 79 |
| | $ | 10 |
|
Total borrowing capacity remaining under the $1.2 billion senior unsecured revolving credit facility (the 2015 revolving credit facility) was $575 million, due to an outstanding balance of $550 million, as well as a reduction of $75 million for letters of credit outstanding at March 31, 2016. In total, Ashland’s available liquidity position, which includes cash, the 2015 revolving credit facility and the accounts receivable securitization facility, was $1,790 million at March 31, 2016, compared to $2,280 million at September 30, 2015.
Capital resources
Debt
The following summary reflects Ashland’s debt as of March 31, 2016 and September 30, 2015.
|
| | | | | | | |
| March 31 |
| | September 30 |
|
(In millions) | 2016 |
| | 2015 |
|
Short-term debt | $ | 694 |
| | $ | 326 |
|
Long-term debt (including current portion and debt issuance cost discounts) (a) | 3,383 |
| | 3,403 |
|
Total debt | $ | 4,077 |
| | $ | 3,729 |
|
| | | |
(a)Includes $26 million and $28 million of debt issuance cost discounts as of March 31, 2016 and September 30, 2015, respectively.
The current portion of long-term debt was $55 million at March 31, 2016 and September 30, 2015. Debt as a percent of capital employed was 60% at March 31, 2016 and 55% at September 30, 2015. At March 31, 2016, Ashland’s total debt had an outstanding principal balance of $4,251 million, discounts of $148 million, and debt issuance costs of $26 million. The scheduled aggregate maturities of long-term debt by year (including
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
the current portion and excluding debt issuance costs) are as follows: $28 million remaining in 2016, $69 million in 2017, $810 million in 2018, $143 million in 2019 and $715 million in 2020.
Accounts receivable securitization
During the December 2015 quarter, the Transfer and Administration Agreement was amended to extend the termination date of the accounts receivable securitization facility from December 31, 2015 to March 22, 2017. No other changes to the agreement within the current year amendments are expected to have a significant impact to Ashland's results of operations and financial position.
Debt covenant restrictions
Ashland's debt contains usual and customary representations, warranties and affirmative and negative covenants, including financial covenants for leverage and interest coverage ratios, limitations on liens, additional subsidiary indebtedness, restrictions on subsidiary distributions, investments, mergers, sale of assets and restricted payments and other customary limitations. As of March 31, 2016, Ashland is in compliance with all debt agreement covenant restrictions.
The 2015 Senior Credit Agreement defines the consolidated leverage ratio as the ratio of consolidated indebtedness minus cash and cash equivalents to consolidated EBITDA (Covenant Adjusted EBITDA) for any measurement period. In general, the 2015 Senior Credit Agreement defines Covenant Adjusted EBITDA as net income plus consolidated interest charges, taxes, depreciation and amortization expense, fees and expenses related to capital market transactions, restructuring and integration charges, noncash stock and equity compensation expense, and any other nonrecurring expenses or losses that do not represent a cash item in such period or any future period; less any noncash gains or other items increasing net income. The computation of Covenant Adjusted EBITDA differs from the calculation of EBITDA and Adjusted EBITDA, which have been reconciled previously on page 41 and 42. In general, consolidated indebtedness includes debt plus all purchase money indebtedness, banker’s acceptances and bank guaranties, deferred purchase price of property or services, attributable indebtedness and guarantees. The maximum consolidated leverage ratios permitted under the 2015 Senior Credit Agreement are as follows: 3.75 from June 30, 2015 through December 31, 2016 and 3.5 from March 31, 2017 and each fiscal quarter thereafter.
The 2015 Senior Credit Agreement defines the consolidated interest coverage ratio as the ratio of Covenant Adjusted EBITDA to consolidated interest charges for any measurement period. The minimum required consolidated interest coverage ratio under the 2015 Senior Credit Agreement during its entire duration is 3.0.
At March 31, 2016, Ashland’s calculation of the consolidated leverage ratio was 3.2, which is below the maximum consolidated leverage ratio permitted under the 2015 Senior Credit Agreement of 3.75. At March 31, 2016, Ashland’s calculation of the consolidated interest coverage ratio was 5.8, which exceeds the minimum required ratio of 3.0. Any change in Covenant Adjusted EBITDA of $100 million would have an approximate 0.3x effect on the consolidated leverage ratio and a 0.6x effect on the consolidated interest coverage ratio. Any change in consolidated indebtedness of $100 million would affect the consolidated leverage ratio by approximately 0.1x.
Credit ratings
Ashland’s corporate credit ratings have remained unchanged from those reported in its Form 10-K filed in November 2015. Standard & Poor’s ratings are BB, while Moody’s Investor Services are Ba1. Moody's Investor Services' outlook remained at stable, while Standard & Poor's remained at negative. Subsequent changes to these ratings may have an effect on Ashland’s borrowing rate or ability to access capital markets in the future.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
Cash projection
Ashland projects that cash flow from operations and other available financial resources, such as cash on hand and revolving credit, should be sufficient to meet investing and financing requirements to enable Ashland to comply with the covenants and other terms of its financing obligations. These projections are based on various assumptions that include, but are not limited to: operational results, working capital cash generation, capital expenditures, divestitures and acquisitions, pension funding requirements and tax payments and receipts.
Based on Ashland’s current debt structure, future annual interest expense is expected to be approximately $170 million to $180 million based on applicable fixed and floating interest rates, assuming interest rates remain stable.
Stockholders' equity
Stockholders’ equity decreased $314 million since September 30, 2015 to $2,723 million at March 31, 2016. This decrease was primarily due to a decline of $500 million for the stock repurchase agreements and regular cash dividends of $48 million. These decreases were partially offset by net income during the period of $176 million, $21 million related to pension and other postretirement obligations, $19 million related to deferred translation gains, $9 million of an unrealized gain on available-for-sale securities, and $9 million for common shares issued under stock incentive and other plans.
Stock repurchase programs
In April 2015, Ashland's Board of Directors approved a new $1 billion share repurchase authorization that will expire on December 31, 2017 (the 2015 stock repurchase program). This authorization replaced the March 2014 authorization of a $1.35 billion common stock repurchase program (the 2014 stock repurchase program), which was completed during the June 2015 quarter, with delivery of the final shares occurring in July 2015. Under both programs, Ashland’s common shares could be repurchased in open market transactions, privately negotiated transactions or pursuant to one or more accelerated stock repurchase programs or Rule 10b5-1 plans. The following summarizes the stock repurchases under these authorizations.
In November 2015, under the 2015 stock repurchase program, Ashland announced that it entered into an accelerated share repurchase agreement (2016 ASR Agreement) with Goldman, Sachs & Co. Under the 2016 ASR Agreement, Ashland paid an initial purchase price of $500 million and received an initial delivery of approximately 3.9 million shares of common stock during November 2015. In February 2016, Goldman, Sachs & Co. exercised their early termination option under the 2016 ASR Agreement and the pricing period was closed. The settlement price, which represents the weighted average price of Ashland's common stock over the pricing period less a discount, was $99.01 per share. Based on this settlement price, the final number of shares repurchased by Ashland that were delivered by Goldman, Sachs, and Co. under the 2016 ASR Agreement was 5.1 million shares. Ashland received the additional 1.2 million shares during the three months ended March 31, 2016 to settle the difference between the initial share delivery and the total number of shares repurchased.
Cash dividends
In May 2015, the Board of Directors of Ashland announced a quarterly cash dividend increase to 39 cents per share to eligible shareholders of record. This amount was paid for quarterly dividends in the first and second quarters of fiscal 2016 and the third and fourth quarters of fiscal 2015, and was an increase from the quarterly cash dividend of 34 cents per share paid during the first and second quarters of fiscal 2015.
Capital expenditures
Ashland is currently forecasting approximately $320 million to $340 million of capital expenditures for 2016, funded primarily from operating cash flows. Capital expenditures were $103 million for the six months ended March 31, 2016 and averaged $259 million during the last three fiscal years.
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
Contractual obligations and commitments
Ashland expects to incur certain costs as a result of the separation, including those that are contingent upon the completion of the separation. Ashland will recognize these costs when appropriate based on applicable U.S. GAAP requirements.
CRITICAL ACCOUNTING POLICIES
The preparation of Ashland’s Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, sales and expenses, and the disclosures of contingent assets and liabilities. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets (including goodwill and other intangible assets), employee benefit obligations, income taxes, other liabilities and receivables associated with asbestos litigation and environmental remediation. These accounting policies are discussed in detail in “Management’s Discussion and Analysis – Critical Accounting Policies” in Ashland’s Annual Report on Form 10-K for the fiscal year ended September 30, 2015. Although management bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, actual results could differ significantly from the estimates under different assumptions or conditions. Management has reviewed the estimates affecting these items with the Audit Committee of Ashland’s Board of Directors. No material changes have been made to the valuation techniques during the six months ended March 31, 2016.
OUTLOOK
As Specialty Ingredients enters the third quarter of fiscal 2016, which is typically its strongest quarter of the fiscal year, Ashland expects sales to increase sequentially reflecting these seasonal patterns and recent sales pipeline gains. In addition, sales for Specialty Ingredients are expected to benefit from the receding effects of foreign currency rates compared to the prior year quarter. Third-quarter sales are expected to be in the range of $555 million to $575 million and Adjusted EBITDA is expected to be slightly above the prior year quarter.
Ashland expects sales for Performance Materials for the upcoming third quarter of fiscal 2016 to be in the range of $235 million to $250 million and Adjusted EBITDA margin is expected to be in the range of 12% to 13%.
For the third quarter of fiscal 2016 Ashland expects Valvoline to continue to report strong financial results across the business. Sales are expected to be approximately $500 million to $510 million in what is typically Valvoline’s seasonally strongest quarter. Adjusted EBITDA margin is expected to be in the range of 23% to 24%.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Ashland’s market risk exposure at March 31, 2016 is generally consistent with the types and amounts of market risk exposures presented in Ashland’s Annual Report on Form 10-K for the fiscal year ended September 30, 2015.
ITEM 4. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures - As of the end of the period covered by this quarterly report, Ashland, under the supervision and with the participation of its management, including Ashland’s Chief Executive Officer and its Chief Financial Officer, evaluated the effectiveness of Ashland’s disclosure controls and procedures pursuant to Rule 13a-15(b) and 15d-15(b) promulgated under the Securities Exchange Act of 1934,
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
MANAGEMENT’S DISCUSSION AND ANALYSIS
as amended. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective as of March 31, 2016.
Changes in Internal Control over Financial Reporting - During the three months ended March 31, 2016, there were no significant changes in Ashland’s internal control over financial reporting, or in other factors, that occurred during the period covered by this quarterly report that have materially affected, or are reasonably likely to materially affect, Ashland’s internal control over financial reporting.
PART II – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
The following is a description of Ashland’s material legal proceedings.
Asbestos-Related Litigation
Ashland is subject to liabilities from claims alleging personal injury caused by exposure to asbestos. Such claims result primarily from indemnification obligations undertaken in 1990 in connection with the sale of Riley Stoker Corporation (Riley), a former subsidiary. Although Riley was neither a producer nor a manufacturer of asbestos, its industrial boilers contained some asbestos-containing components provided by other companies.
Hercules, a wholly-owned subsidiary of Ashland, is also subject to liabilities from asbestos-related personal injury lawsuits involving claims which typically arise from alleged exposure to asbestos fibers from resin encapsulated pipe and tank products which were sold by one of Hercules’ former subsidiaries to a limited industrial market.
Ashland and Hercules are also defendants in lawsuits alleging exposure to asbestos at facilities formerly or presently owned or operated by Ashland or Hercules.
For additional detailed information regarding liabilities arising from asbestos-related litigation, see Note L of Notes to Condensed Consolidated Financial Statements in this quarterly report on Form 10-Q.
Environmental Proceedings
(a) CERCLA and Similar State Law Sites – Under the Comprehensive Environmental Response, Compensation and Liability Act of 1980 and similar state laws, Ashland and its subsidiaries may be subject to joint and several liability for cleanup costs in connection with alleged releases of hazardous substances at sites where it has been identified as a “potentially responsible party” (PRP). As of March 31, 2016, Ashland and its subsidiaries have been identified as a PRP by U.S. federal and state authorities, or by private parties seeking contribution, for the cost of environmental investigation and/or cleanup at 84 waste treatment or disposal sites. These sites are currently subject to ongoing investigation and remedial activities, overseen by the United States Environmental Protection Agency (USEPA) or a state agency, in which Ashland or its subsidiaries are typically participating as a member of a PRP group. Generally, the types of relief sought include remediation of contaminated soil and/or groundwater, reimbursement for past costs of site cleanup and administrative oversight and/or long-term monitoring of environmental conditions at the sites. The ultimate costs are not predictable with assurance.
(b) Hattiesburg, Mississippi Resource Conservation and Recovery Act Matter – In November 2008, the Mississippi Department of Environmental Quality (MDEQ) issued a Notice of Violation to Hercules’ now-closed Hattiesburg, Mississippi manufacturing facility alleging that a process water impoundment basin at the facility had been operated as a hazardous waste storage and treatment facility without a permit in violation of the Resource Conservation and Recovery Act. In May 2011, the USEPA issued an inspection report from a September 2010 inspection with allegations similar to those of the MDEQ and promulgated an information request. Ashland has been working with the MDEQ and USEPA to settle this matter in the context of the shutdown and ongoing remediation of the Hattiesburg facility. The USEPA proposed a settlement penalty in excess of $100,000. While it is reasonable to believe that this matter will involve a penalty from the MDEQ and/or the USEPA exceeding $100,000, the potential penalty with respect to this enforcement matter should not be material to Ashland.
(c) Lower Passaic River, New Jersey Matters – Ashland, through two formerly owned facilities, and ISP, through a now-closed facility, have been identified as PRPs, along with approximately 70 other companies (the Cooperating Parties Group or the CPG), in a May 2007 Administrative Order of Consent (AOC) with the USEPA. The parties are required to perform a remedial investigation and feasibility study (RI/FS) of the entire 17 miles of the Passaic River. In June 2007, the EPA separately commenced a Focused Feasibility Study (FFS) as an interim measure. In accordance with the 2007 AOC, in June 2012 the CPG voluntarily entered into another AOC for an interim removal action focused solely at mile 10.9 of the Passaic River. The allocations for the 2007 AOC and the 2012 removal action are based on interim allocations, are immaterial and have been accrued. In April 2014, the EPA released the FFS. The CPG submitted the Draft RI/FS Report on April 30, 2015. The EPA has released the FFS Record of Decision for the lower 8 miles and
issued a notice letter to all identified PRPs advising that they are first requesting the Occidental PRPs to conduct the remedial design. The release of the FFS Record of Decision did not have a material adverse impact on Ashland’s business and financial operations; however, there are a number of contingencies in the future that could possibly have a material impact including adverse rulings or verdicts, allocation proceedings and related orders.
(d) Zwijndrecht Plant Matter - Between August 2012 and January 2014, Dutch environmental authorities found several violations of a waste water discharge permit by Ashland Industries Nederland B.V., as owner of the manufacturing site at Zwijndrecht, The Netherlands. As a result, administrative penalties and sanctions totaling €350,000 were paid during calendar years 2013 and 2014. In addition, Dutch authorities announced prosecution with regards to some permit violations. Ashland has initiated a settlement proposal and is awaiting a response to the proposal. While it is reasonable to believe that this matter will involve an additional penalty exceeding $100,000, the potential liability with respect to this matter should not be material to Ashland.
For additional information regarding environmental matters and reserves, see Note L of Notes to Condensed Consolidated Financial Statements in this quarterly report on Form 10-Q.
Other Pending Legal Proceedings
In addition to the matters described above, there are other various claims, lawsuits and administrative proceedings pending or threatened against Ashland and its current and former subsidiaries. Such actions are with respect to commercial matters, product liability, toxic tort liability and other environmental matters which seek remedies or damages, some of which are for substantial amounts. While Ashland cannot predict with certainty the outcome of such actions, it believes that adequate reserves have been recorded and losses already recognized with respect to such actions were immaterial as of March 31, 2016. There is a reasonable possibility that a loss exceeding amounts already recognized may be incurred related to these actions; however, Ashland believes that such potential losses were immaterial as of March 31, 2016.
ITEM 1A. RISK FACTORS
During the period covered by this report, there were no material changes, other than noted below, from the risk factors previously disclosed in Ashland’s Annual Report on Form 10-K for the fiscal year ended September 30, 2015.
Ashland’s plan to separate into two independent, publicly traded companies is subject to various risks and uncertainties and may not be completed in accordance with the expected plans or anticipated timeline, or at all, and will involve significant time and expense, any of which could negatively impact our businesses.
On September 22, 2015, Ashland announced plans to separate its Valvoline business from its Specialty Ingredients and Performance Materials businesses (the “separation”) in a structure that is expected to be tax free for Ashland shareholders. On April 13, 2016, Ashland announced that it plans to pursue an initial public offering of up to 20 percent of the common stock of Valvoline as a first step in the separation (the “initial separation”). Ashland expects to complete the proposed offering during the fourth quarter of calendar year 2016. Any such offering will be made only by a prospectus filed with the Securities and Exchange Commission, and this filing shall not constitute an offering of Valvoline common stock. Ashland currently expects that it would distribute the remaining common stock of Valvoline to Ashland’s shareholders (the “final separation”) upon the expiration of the lock-up (typically six months after completion of the proposed offering). Each of the initial separation and the final separation is subject to final approval from Ashland’s board of directors. In addition, other unanticipated developments, including changes to the competitive environment for Valvoline’s or new Ashland’s respective businesses, possible delays in obtaining or failure to obtain tax opinions, regulatory or other approvals or clearances to approve or facilitate the separation, uncertainty in financial markets and other challenges in executing the separation as planned, could delay or prevent the initial separation or the final separation, or cause the separation to occur on terms or conditions that are different or less favorable than expected.
Ashland expects that the process of completing the separation will be time-consuming and involve significant costs and expenses, which may be significantly higher than those currently anticipated and may not yield a discernible benefit if the separation is not completed. Also, the time and energy required from Ashland’s senior management and other employees to plan and execute the separation may lead to increased costs, increased expenses, negative effects on relationships with business partners, suppliers, and customers, disruptions in operations and ultimately harm its
businesses. Ashland may also experience difficulty attracting, retaining and motivating employees during the pendency of the separation, which could also harm its businesses.
If the separation is completed, there is a further risk that the sum of the value of the two independent, publicly traded companies will be less than the value of Ashland before the separation. There is also a risk that the completed separation will not meet all of the intended financial, strategic, and operational benefits that were the impetus for the decision to separate the company.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Share repurchase activity during the three months ended March 31, 2016 was as follows:
|
| | | | | | | | | | | | | | | | | | |
Issuer Purchases of Equity Securities |
Q2 Fiscal Periods | Total Number of Shares Purchased | Average Price Paid Per Share, including commission | | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | | Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in millions)(1) |
January 1, 2016 to January 31, 2016: | — |
| | | — |
| | — |
| | $ | 500 |
| |
Employee Tax Withholdings | 12,513 |
| (2 | ) | | $ | 101.15 |
| (2 | ) | | | | |
February 1, 2016 to February 29, 2016: | | | | | |
|
| | 500 |
| |
ASR Agreement | 1,176,061 |
| (3 | ) | | 99.01 |
| (3 | ) | 1,176,061 |
| (3 | ) | | |
March 1, 2016 to March 31, 2016 | — |
| | | — |
| | — |
| | 500 |
| |
Total | 1,188,574 |
| | | | | 1,176,061 |
| | $ | 500 |
| |
(1)In April 2015, the Company's Board of Directors authorized a program to repurchase up to $1 billion of the company's stock, with the authorization expiring December 31, 2017. The Company's share repurchase program does not obligate it to acquire any specific number of shares. Under the program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 of the Exchange Act. After entering into the ASR agreement described below in footnote 3, $500 million remains available for repurchase under this authorization.
(2)Shares withheld from employees to cover their withholding requirements for personal income taxes related to the vesting of restricted stock.
(3)In November 2015, the Company entered into an accelerated share repurchase (ASR) agreement with a financial institution to purchase $500 million of the Company's common stock. In exchange for an up-front payment of $500 million, the financial institution committed to deliver shares during the ASR's purchase period. In February 2016, the financial institution exercised its early termination option and the purchase period was closed. The settlement price, which represents the weighted average price of Ashland’s common stock over the pricing period less a discount, was $99.01 per share. The Company received 1,176,061 shares from the financial institution to settle the difference between the initial share delivery and the total number of shares repurchased. The up-front payment of $500 million was accounted for as a reduction to stockholders' equity in the Company's Condensed Consolidated Balance Sheets.
ITEM 6. EXHIBITS
|
| |
(a) Exhibits | |
10.1* | Tenth Amendment dated as of March 24, 2016 to the Transfer and Administration Agreement dated as of August 31, 2012, among Ashland Inc., CVG Capital III LLC, the Originators, the Investors, Letter of Credit Issuers, Managing Agents and Administrators party thereto, and The Bank of Nova Scotia, as Agent for the Investors. |
| |
12* | Computation of Ratio of Earnings to Fixed Charges. |
| |
31.1* | Certificate of William A. Wulfsohn, Chief Executive Officer of Ashland pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| |
31.2* | Certificate of J. Kevin Willis, Chief Financial Officer of Ashland pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| |
32* | Certificate of William A. Wulfsohn, Chief Executive Officer of Ashland, and J. Kevin Willis, Chief Financial Officer of Ashland pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| |
101.INS** | XBRL Instance Document. |
| |
101.SCH** | XBRL Taxonomy Extension Schema Document. |
| |
101.CAL** | XBRL Taxonomy Extension Calculation Linkbase Document. |
| |
101.DEF** | XBRL Taxonomy Extension Definition Linkbase Document. |
| |
101.LAB** | XBRL Taxonomy Extension Label Linkbase Document. |
| |
101.PRE** | XBRL Taxonomy Extension Presentation Linkbase Document. |
*Filed herewith.
**Attached as Exhibit 101 to this report are the following documents formatted in XBRL (Extensible Business Reporting Language): (i) Statements of Consolidated Comprehensive Income for the three and six months ended March 31, 2016 and March 31, 2015; (ii) Condensed Consolidated Balance Sheets at March 31, 2016 and September 30, 2015; (iii) Statements of Consolidated Stockholders’ Equity at March 31, 2016; (iv) Statements of Condensed Consolidated Cash Flows for the six months ended March 31, 2016 and March 31, 2015; and (v) Notes to Condensed Consolidated Financial Statements.
SM Service mark, Ashland or its subsidiaries, registered in various countries.
™ Trademark, Ashland or its subsidiaries, registered in various countries.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
| |
| Ashland Inc. |
| (Registrant) |
April 27, 2016 | /s/ J. Kevin Willis |
| J. Kevin Willis |
| Senior Vice President and Chief Financial Officer (on behalf of the Registrant and as principal financial officer) |
EXHIBIT INDEX
|
| |
(a) Exhibits | |
10.1* | Tenth Amendment dated as of March 24, 2016 to the Transfer and Administration Agreement dated as of August 31, 2012, among Ashland Inc., CVG Capital III LLC, the Originators, the Investors, Letter of Credit Issuers, Managing Agents and Administrators party thereto, and The Bank of Nova Scotia, as Agent for the Investors. |
| |
12* | Computation of Ratio of Earnings to Fixed Charges. |
| |
31.1* | Certificate of William A. Wulfsohn, Chief Executive Officer of Ashland pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| |
31.2* | Certificate of J. Kevin Willis, Chief Financial Officer of Ashland pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| |
32* | Certificate of William A. Wulfsohn, Chief Executive Officer of Ashland, and J. Kevin Willis, Chief Financial Officer of Ashland pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| |
101.INS** | XBRL Instance Document. |
| |
101.SCH** | XBRL Taxonomy Extension Schema Document. |
| |
101.CAL** | XBRL Taxonomy Extension Calculation Linkbase Document. |
| |
101.DEF** | XBRL Taxonomy Extension Definition Linkbase Document. |
| |
101.LAB** | XBRL Taxonomy Extension Label Linkbase Document. |
| |
101.PRE** | XBRL Taxonomy Extension Presentation Linkbase Document. |
*Filed herewith.
**Submitted electronically with this report.